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ABSTRACT
Chitosan hydrogels are increasingly being used as vehicles for the controlled delivery of drugs,
cells and proteins for various biomedical applications. The most important advantages offered by
chitosan include biocompatibility, biodegradability, antimicrobial activity and non-toxicity.
Glycol chitosan (GC) is a derivative of chitosan that is gaining interest lately because of its water
solubility. Previous studies in the lab demonstrated the feasibility of developing injectable
enzymatically crosslinked hydrogels from GC. One of the disadvantages of GC hydrogel is its lack
of biodegradation in vitro and in vivo. This work is the first attempt at studying acetylated
derivatives of GC as a biodegradable hydrogel platform for different therapeutic applications.
Enzymatic crosslinking was used to prepare biodegradable injectable hydrogels from acetylated
GC as vehicles for protein delivery. Results indicated that the degradation-dependent protein
release from the hydrogels increased with increasing degree of acetylation, which presents a
unique mechanism to tailor macromolecule release properties. The cytocompatibility of the
acetylated hydrogels was confirmed by following the viability of encapsulated osteoblast cells.
Dependence of in vivo degradation of the hydrogels on the degree of acetylation was confirmed
by subcutaneous implantation of the hydrogels in mouse model. Another disadvantage of GC
hydrogel is its inability to support cell spreading upon cell encapsulation. Composite hydrogels
prepared by incorporating gelatin in GC showed significant improvement in cell spreading as a
function of gelatin concentration. However, the lack of uniform cell spreading in the composite
hydrogels warrants the need to develop alternative approaches to incorporate cell-adhesive
moieties in GC to improve cell adhesion and cell spreading in the hydrogel.
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CHAPTER 1- INJECTABLE CHITOSAN HYDROGELS FOR
BIOMEDICAL APPLICATIONS
1. Introduction
1.1. Hydrogels
Hydrogels are three dimensional networks of hydrophilic polymers that have the ability to
imbibe aqueous fluids and swell while remaining mechanically stable (1-3). Hydrogels are
attractive candidates for biomedical applications mainly due to their biocompatibility,
biodegradability, ability to mimic natural tissue and support cell viability and functions (3, 4). Due
to the excellent permeability of hydrogels, they are used as cell and drug delivery vehicles.
Hydrogels used for regenerative engineering applications can be either preformed or injectable.
Preformed hydrogels are fabricated in vitro followed by transplantation in vivo (5). Preformed
hydrogels can be prepared in different forms – membranes, coatings, pressed powder matrices,
molded solids, encapsulated solids, and micro-particles – depending on the intended application
(1-3, 6). On the other hand, injectable hydrogels are formed by injecting polymer solutions into
the body that can then form gels in situ (5). Injectable hydrogels have shown potential for
minimally invasive delivery of cells as well as biomolecules because their physical properties can
be easily tailored. Hydrogels are also useful for targeted, controlled and sustained release of drugs
and bioactive molecules. Drug releasing mechanisms in hydrogels are mainly classified as
diffusion-controlled, swelling-controlled or degradation-controlled (1). Studies have shown the
feasibility of developing stimuli-responsive hydrogels, wherein the gel properties can be
modulated by changing the external environmental conditions such as pH, temperature and ionic
strength. These smart hydrogel systems are useful as cell or drug delivery systems (2). Hydrogels
used in biomedical applications can also be classified in terms of whether they are derived from
1

natural or synthetic polymers. Table 1.1 provides a list of some of the natural and synthetic
polymers used for hydrogel preparation. Hydrogels made from natural polymers have the
advantages of bioactivity, biocompatibility and biodegradability but suffer from low mechanical
strength, poor reproducibility, and the potential presence of pathogens that may lead to immune
responses. On the other hand, hydrogels derived from synthetic polymers can be effectively and
consistently tailored to provide desired mechanical properties and degradability, but lack inherent
bioactivity (1).

Table 1.1: Natural and synthetic polymers used in hydrogel fabrication (7, 8)
Natural polymers

Synthetic polymers

Agarose

Poly(ethylene glycol) (PEG) and its derivatives

Chitosan

Pluronics

Cellulose

Poly Acrylamide (PAAm)

Hyaluronic acid

Polyvinylpyrrolidone (PVP)

Elastin

Poly Acrylic acid (PAA)

Collagen

Poly N-isopropylacrylamide (PNIPAM)

Gelatin

Poly (vinyl alcohol) (PVA)

Chondroitin sulfate

Poly (hydroxyethyl methacrylate) (PHEMA)

1.2. Injectable hydrogels
Injectable hydrogels can be easily delivered to even the deepest tissue inside the body in a
minimally invasive manner and therefore have many advantages when compared to preformed
hydrogels. Since the injectable systems exit as free-flowing liquid solutions that are easy to handle,
they can form gels according to the size and shape of the wound/defect area (9), can provide
2

homogenous distribution of cells in gels (6), and can fill the defect area completely by successfully
providing neovascularization to the area from healthy tissue. In contrast, conventional, preformed
hydrogels are not easy to handle, require multiple surgeries, cannot reach the complete depth of
the tissue, lead to incomplete defect filling, and are less adaptive to the defective area (10). The
most commonly used injectable hydrogels are thermoresposive/thermogelling, pH-responsive,
photocrosslinkable and enzymatically crosslinkable hydrogels. Thermogelling injectable
hydrogels are formed when they are exposed to body temperature. This happens due to a change
in solubility and phase transition due to the change in temperature. pH-responsive hydrogels, as
the name suggests, are formed due to change in pH. Photocrosslinkable hydrogels are formed when
the polymer solution is exposed to electromagnetic radiations such as ultraviolet (UV) and visible
light. When the light interacts with the photoinitiators that are incorporated along with the polymer
solution, free radicals are generated and crosslinking is initiated, thereby leading to hydrogel
formation. Enzymatic crosslinking is extensively used for preparing injectable hydrogels because
the process uses enzymes for crosslinking and therefore happens at the physiological temperature
inside the body. The crosslinking process is generally mild

and non-toxic resulting in

biocompatible gels (10).

Figure 1.1: Schematic representation of injectable hydrogel for tissue engineering application (6)

3

1.3. Chitosan
Chitosan is derived from chitin, which is a naturally occurring linear polysaccharide. Chitin
is comprised of repeating units of N-acetyl-D-glucosamine, as shown in Figure 1.2.

Figure 1.2: Structure of chitin (11)

Crab and shrimp shells currently serve as the common source of chitin. Despite its favorable
structural and biological properties, the insolubility of chitin in water and common organic
solvents prevents its extensive use for biomedical applications (11, 12). Hence, several approaches
have been investigated to increase the aqueous solubility of chitin, including deacetylation (12),
carboxymethylation (13) and sulfation (14). Among these, deacetylation of chitin by alkaline
treatment is the most commonly used approach. The derivative of chitin with degree of
deacetylation of approximately 50% is known as “chitosan”, which is soluble in aqueous acidic
solutions (12). Chitosan is a copolymer comprising of N-acetyl-D-glucosamine and deacetylated
D-glucosamine units (11, 12, 14-17). The structure of chitosan obtained by the complete
deacetylation of chitin is shown in Figure 1.3.

4

Figure 1.3: Preparation of chitosan by the complete deacetylation of chitin (11)

The most commonly used methods to determine the degree of deacetylation are 1H (liquid
state),

13

C (solid state) and

15

N (solid state) nuclear magnetic resonance (NMR) spectroscopy.

Among these, 1H is extensively used to determine acetyl groups in soluble samples. Other methods
include infra-red (IR) and UV spectrometry, elemental analysis, potentiometric titration, and
enzymatic reaction (12). Degree of deacetylation can significantly affect the biological as well as
physiochemical properties of chitosan (18). Chitosan in solid state is reported to be a semicrystalline polymer (12). Cartier et al determined the crystallinity of chitosan using X-ray and
electron diffraction methods that allow calculation of the unit cell parameters. Electron diffraction
of fully deacetylated chitosan single crystal indicated an orthorhombic unit cell with lattice
parameters a = 0.807 nm, b = 0.844 nm, c =1.034 nm (19). Molecular weight is another important
parameter that determines the physiochemical and biological properties of chitosan. It varies with
the chitin source from which chitosan is obtained (18). Several methods can be used to determine
the molecular weight of chitosan. The selection of an appropriate solvent system that does not lead
to significant aggregation of chitosan is necessary while determining the molecular weight. A
solution of 0.3 M acetic acid/0.2 M sodium acetate (pH = 4.5) has been reported to be a suitable
5

solvent system (20). The Mark-Houwink equation given below [1] is commonly used to determine
the viscosity average molecular weight of chitosan

[ ]  KM a      [1]
Where η is intrinsic viscosity, M is molecular weight, and K and a are experimentally determined
parameters for a given solvent system. If K and a are known, molecular weight can then be
obtained by intrinsic viscosity measurements (21).
As mentioned earlier, the main motivation behind modifying chitin to obtain chitosan is
to take advantage of the improved solubility. In solutions of pH less than ~6.0, the amine groups
in chitosan become protonated, thereby allowing chitosan to be soluble in aqueous acidic solutions.
The protonation does not occur in basic solutions, leading to a solubility-insolubility transition at
pH value ~6.5 (15). The exact pH above which chitosan becomes insoluble, however, depends on
the degree of deacetylation, the distribution of the acetyl groups on the linear chain, and the
molecular weight. Another advantage of chitosan is that it can be chemically modified using the
reactive amine group at the C-2 position or hydroxyl groups at the C-3 and C-6 positions to alter
its functionality. Particularly, this allows the functionalization of chitosan for different biological
applications (12). Table 1.2 lists some of the chemically modified chitosan derivatives that are
water soluble along with some of their biomedical applications.

6

Table 1.2: Functionalized derivatives of chitosan (12, 22)
Derivatives of chitosan

Solubility

Example of applications

Reference

Carboxymethylchitosan

Water soluble

Drug delivery,

(23, 24)

Tissue engineering
Glycol chitosan

Water soluble

Drug delivery

(25, 26)

PEG-grafted chitosan

Water soluble

Drug delivery,

(27)

Tissue engineering
Sulfated chitosan

Water soluble

Tissue engineering,

(28, 29)

Anticoagulant
N-methylene phosphonic chitosan Water soluble
Cyclodextrin grafted chitosan

Water soluble

Gene delivery

(30, 31)

Drug delivery

(32)

1.4. Chitosan hydrogels
Chitosan has been widely investigated for a variety of applications in the biomedical
industry. The beneficial properties of chitosan are its biocompatibility, biodegradability (33),
antimicrobial activity (34), mucoadhesivity (35), wound healing and hemostatic properties (36),
and low toxicity (33). Biodegradability of chitosan is dependent on different factors such as the
degree of deacetylation, distribution of amine groups, presence of acetyl groups, and molecular
weight of the polymer (17). Chitosan can be degraded using enzymes such as lysozyme, which is
a glycosidic hydrolase present in the human body. Lysozyme is reported to hydrolyze the β (1-4)
linkages between N-acetylglucosamine and glucosamine (37). Therefore, the degree of acetylation
of chitosan plays an important role in its enzyme-mediated degradation. Chitosan with a higher
degree of deacetylation undergoes limited degradation whereas increasing acetylation results in
higher degradation (38). Antimicrobial property of chitosan stems from its interaction with the
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negatively charged cell surfaces, which affects cellular permeability, or by its interaction with
DNA, which inhibits microbial RNA synthesis (39). Mucoadhesive property of chitosan arises
from its positively charged amine groups that can interact with the negatively charged groups in
the mucin molecule (35). Hemostatic property is due to the presence of positively charged groups
in chitosan that interact with the negatively charged surfaces of blood cells (17); chitosan-based
hemostatic bandage called Hemcon® has been FDA-approved (40). Due to these unique biological
properties, extensive research has gone in to develop chitosan-based hydrogels for biomedical
applications. Both physical and chemical crosslinking methods can be used to develop chitosan
hydrogels. Physically crosslinked hydrogels are formed by physical interactions such as
electrostatic, hydrophobic or hydrogen bonding between the polymer chains. Hydrogel formation
can be induced by mixing the constituents under suitable conditions to initiate the gelation.
Physical crosslinking is usually triggered by stimuli such as pH and temperature. Controlling the
concentration of chitosan with respect to that of the other components and thereby controlling the
polymer interactions has been shown to significantly control gel properties (17, 41). Chemically
crosslinked hydrogels are formed as a result of covalent bonding (17). Chemical crosslinking of
chitosan can be achieved by using different crosslinkers or by modifying the -NH2 or -OH groups
present in the polymer (41).

1.5. Injectable chitosan hydrogels
1.5.1. Preparation of thermogelling injectable chitosan hydrogels
Thermogelling chitosan hydrogels undergo gelation in response to changes in temperature
(42). Thermogelling chitosan hydrogels have been investigated as injectable carriers for
biomedical applications (43). One of the most extensively studied thermogelling chitosan
formulations is the chitosan-β-glycerophosphate (β-GP) system that can undergo sol-gel transition
8

at or near physiological temperature. Chitosan/β-GP system has been investigated mainly for cell,
drug, or growth factor delivery due to the mild gelation process and the minimally invasive manner
of delivery (44). For bone regeneration, Niranjan et al synthesized a novel thermosensitive carrier
comprising of chitosan/β-GP doped with zinc. Metals such as zinc have been shown to provide
thermal resistance and antibacterial property. Briefly, chitosan was dissolved in 0.1 M acetic acid.
Zinc sulfate solution was added under stirring at a 1:1 (v/v) ratio followed by the addition of β-GP
at a 1:9 (v/v) ratio. Addition of β-GP to the chitosan solution changed the solution pH from 3 to 7.
Gelation time of zinc-doped chitosan/β-GP solution was ~5 min. Gelation resulted in a porous
hydrogel with a pore size of around 200 µm (45). Liu et al used chitosan-4-thio-butylamidine (CSTBA), (β-GP) and nano-hydroxyapatite (nano-HA) to develop a thermoresponsive composite
hydrogel that can gel in situ. Thiolated chitosan can dissolve in neutral pH unlike unmodified
chitosan. The hydrogel was prepared by adding nano-HA powder to CS-TBA solution under
continuous stirring followed by dropwise addition of β-GP solution. The final solution was kept at
37 oC for 10 min for gel formation (46). The physical crosslinking has been attributed to the
increased hydrogen bonding and hydrophobic attraction between chitosan chains at higher pH (47,
48). Additionally, thiol groups of CS-TBA also contributed to the gel formation through intra/inter-molecular disulfide bond formation; the process was found to be time-dependent and
temperature-independent (49). The gelation process was found to be dependent on factors such as
concentration of the gel constituents and degree of deacetylation of the chitosan (46). For instance,
an increase in deacetylation of chitosan has been shown to significantly decrease gelation time
(50). Scanning electron microscopy (SEM) analysis showed that the hydrogel had a pore size of
40-80 µm. The presence of thiol group led to higher storage modulus (G’) and loss modulus (G”)
for CS-TBA/β-GP/HA hydrogels in comparison to the unmodified CS/β-GP/HA hydrogels,
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presumably due to the additional disulfide linkages (46). In addition to β-GP, inorganic phosphate
salts have also been shown to impart thermogelling property to chitosan. Nair et al prepared an
injectable thermogelling chitosan-inorganic phosphate hydrogel. Briefly, chitosan was dissolved
in 0.5% acetic acid solution with pH ~5.6. Addition of ammonium hydrogen phosphate (AHP) to
chilled chitosan solution increased the pH to 7-7.2 and the resultant solution showed effective solgel transition at or near physiological temperature. Depending on the amount of AHP, the gelling
time was variable from 5 min to 30 h. Gelling time decreased with an increase in the concentration
of AHP and chitosan. The mechanism of thermogelation is presumed to be a combination of
electrostatic as well as hydrophobic attractions, similar to that of chitosan/β-GP solution (51). Nisoproplyacrylamide (NIPAM) is another material with inherent thermoresponsive properties.
Chen et al developed a thermoresponsive chitosan hydrogel in which chitosan acted as the
backbone on which poly (N-isopropylacrylamide) (PNIPAM) with a carboxylic acid end group
was grafted. PNIPAM is reported to remain soluble under its lower critical solution temperature
(LCST) but forms a gel when the temperature is increased above LCST. This mechanism can be
explained as follows: increasing temperature above LCST causes the release of water molecules
attached to the isopropyl moieties of the polymer, leading to a compact form with an increase in
intra-/inter-molecular hydrophobic attraction between the isopropyl groups (22, 52, 53). Due to
this property, PNIPAM grafting to natural polymers is widely used to impart thermogelling
properties to these polymers. The grafting of PNIPAM to chitosan was done using 1-ethyl-3- (3dimethylaminopropyl) carbodiimide hydrochloride (EDC)/N-hydroxysulfosuccinimide (NHS)
chemistry, wherein the carboxylic acid group of PNIPAM-COOH was linked to the amine group
of the chitosan. The reaction was carried out at 25 oC for 12 h followed by purification using
thermoprecipitation and dialysis. A porous hydrogel was then prepared by re-dissolving the
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polymer and incubating at 37 oC. Gel formation was observed to be faster with an increase in the
concentration of PNIPAM grafted on the chitosan. SEM analysis of the hydrogels showed a pore
size of 10-40 µm. The study also revealed that phase-transition of the hydrogel was completely
reversible, implying that the conjugated PNIPAM retained its property in the gel (54).

1.5.1.1. Biomedical applications
Dessi et al developed a thermosensitive β-tricalcium phosphate-chitosan hydrogel in the
presence of β-GP and glyoxal to impart physical and chemical gelation. The presence of βtricalcium phosphate in the in situ-gelling hydrogel resulted in a significant increase in cell
attachment and proliferation (55). In-situ-gelling thermosensitive hydrogels made from chitosan/βGP are used as carriers for lentiviral vector that expresses neurotropin-3. Use of this lentiviral
system may have the potential for repairing injuries to the central nervous system by providing
sustained release of the coded protein for longer durations (56). In situ-forming thermosensitive
chitosan/β-GP hydrogel was investigated as a carrier for liposomes containing ofloxacin drug. The
carrier provided extended transcorneal penetration of the drug, resulting in decreased side effects
caused by the drug and reducing the frequency at which the drug was administered to the patient
(57). Zhang et al used the insulating effect of chitosan-based thermosensitive hydrogels for
microwave-assisted ablation of liver tissue. In vivo experiments performed in rabbits showed that
the hydrogel formed in situ had the ability to protect the nearby stomach wall during microwave
ablation

of

liver

tissue

(58).

Cheng

et

al

used

an

injectable

thermosensitive

chitosan/gelatin/glycerol phosphate (C/G/GP) hydrogel for the controlled delivery of ferulic acid
(FA). FA is an antioxidant and can relieve H2O2-induced oxidative stress on the nucleus pulposus
(NP) cells. Controlled delivery of FA from the hydrogel decreased the oxidative stress on NP cells
and showed a decrease in cellular apoptosis (59). The potential of injectable thermosensitive
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chitosan-pluronic hydrogel as a chondrocyte delivery system was demonstrated by encapsulating
bovine chondrocytes. The encapsulated cells in chitosan gel showed enhanced cell proliferation
and glycosaminoglycan production for 28 days when compared to cells encapsulated in alginate
hydrogel (60). Another study investigated the potential of thermosensitive chitosan hydrogel for
three dimensional culture of neuronal cells. The neuronal cells cultured in a poly-D-lysine (PDL)immobilized chitosan/GP hydrogel showed good viability with larger cell bodies (61). Injectable
thermosensitive poly (organophosphazene) hydrogel loaded with galactosylated chitosan-gPEI/DNA complexes showed excellent transfection in vitro in HepG2 and in vivo in BALB/c mice.
Results indicated that the galactosylated hydrogel complex was less toxic and was able to
accumulate in the liver over time, indicating better hepatocyte targeting (62). Chitosan hydrogels
have also been investigated to repair the cornea using stem cells. Chein et al used an injectable,
thermogelling, amphipathic carboxymethyl-hexanoyl chitosan hydrogel as a delivery vehicle for
human keratinocyte reprogrammed to induce pluripotent stem cells (iPSCs). Thermogelation
occurred by the addition of β-GP. The study demonstrated the efficacy of the hydrogels for cellbased healing of corneal wounds (63). Miguel et al evaluated a thermoresponsive chitosan-agarose
hydrogel for wound dressing application. Thermoresponsive nature was imparted to the system by
agarose. In vitro and in vivo studies indicated that the hydrogel had the ability to provide woundhealing environment by preventing water loss and also had bactericidal properties that are essential
for an ‘ideal’ wound dressing material (9). Figure 1.4 shows histological section of tissue samples
isolated from the saline control group and chitosan-agarose hydrogel. The presence of hydrogel
led to the complete re-epithelialization of the wound without signs of acute inflammation.
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Figure 1.4: Hematoxylin and eosin-stained sections of tissue samples after 7, 14 and 21 days.
(A) treated with saline solution (B) treated with CAH (3% ag–1.5% Ch) (9).

1.5.2. Preparation of pH-responsive injectable chitosan hydrogels
In addition to temperature, pH of the solution can also trigger polymer gelation. Many of
these systems are pH-responsive and can undergo changes in shape, swelling and release properties
depending on the pH of the environment. pH-responsive hydrogels are mostly used in drug
delivery and biosensor applications (64). Chitosan is known to exhibit pH-sensitive behavior
because of the amine groups, which, when protonated, become soluble in acidic media. On the
other hand, this makes chitosan insoluble in basic and neutral pH (65). Studies have shown that
injectable in situ-forming hydrogels can be developed using the pH-responsive properties of
chitosan derivatives. Chiu et al designed an injectable hydrogel from N-palmitoyl chitosan (NPCS)
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that exhibits pH-responsive changes in properties within a pH range of 6.5 to 7. The polymer
solution at pH 6.5 exhibits sol-gel transition when injected using a needle as droplets into a saline
solution at pH 7.4. The immediate gelation has been attributed to the physical crosslinking of the
outer layer of the palmitoyl group at pH 7.4 while the inner core still remained at pH 6.5. With
time, the physical crosslinking proceeded throughout the gel, thereby making the transparent gel
opaque. The entire bead was shown to be crosslinked within 30 min. In vivo study confirmed that
when sterile N-palmitoyl chitosan solution was injected subcutaneously in winstar rat, hydrogel
formation was observed in the injected area, demonstrating its utility as an injectable delivery
system. Figure 1.5 shows the synthesis of NPCS and its gelation in vivo. The mechanism behind
the gelation is that, at lower pH, charge repulsion between the protonated amine groups is more
prominent. As pH increases, the hydrophobic interaction of the palmitoyl groups becomes
dominant, which causes the polymer to condense, thereby increasing the intermolecular physical
crosslinking (66).

Figure 1.5: Schematic showing the synthesis of N-palmitoyl chitosan (NPCS) and the pHtriggered hydrogelation of aqueous NPCS injected into the subcutaneous space of rat model (66)
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1.5.2.1. Biomedical applications
Li et al prepared an injectable hydrogel from phenylboronic-modified chitosan and
oxidized dextran. They were able to incorporate anticancer drugs by in situ-crosslinking; the
hydrogel showed controlled release of the drug upon change of pH as well as change of glucose
concentration. In addition, they were able to culture cells in the hydrogel that remained viable and
showed proliferation (67). Ding et al synthesized an injectable hydrogel using glycol chitosan
(GC) and benzaldehyde capped with poly (ethylene glycol)-block-poly (propylene glycol)-blockpoly (ethylene glycol) (PEO-PPO-PEO). The hydrogel was responsive to pH and temperature
change and showed the potential for controlled release of hydrophobic as well as hydrophilic
drugs. The hydrogel was also shown to be biocompatible during implantation in rat model (68).

1.5.3. Preparation of photocrosslinked injectable chitosan hydrogels
Photocrosslinkable hydrogels have been extensively investigated as scaffolds for tissue
engineering (69), drug delivery (70), bioadhesivity (71) and endoscopic treatments (72).
Photocrosslinkable hydrogels can be prepared in situ and are therefore potential candidates to
develop minimally invasive delivery systems (73). Tsuda et al prepared a photocrosslinked
chitosan hydrogel (Az-CS-LA) using chitosan (CS) incorporated with azide (Az) and lactose (LA)
functional groups. The lactose group made the Az-CS-LA polymer water soluble. Briefly, the
hydrogels were prepared by exposing a 20 mg/mL solution of Az-CS-LA to UV light for 30 s (74).
Gelation time was dependent on the intensity of UV radiation; the higher the intensity, the lower
was the gelation time. The mechanism behind gelation is that during UV irradiation, the azide
group (-N3) releases N2 and gets converted to nitrene, which is a very reactive group. These nitrene
groups either interact with other nitrene groups or with the amine groups of chitosan, resulting in
the formation of azo groups (−N=N−) causing gelation (75). The hydrogels showed higher sealing
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strength when compared to fibrin glue. Apart from this, light-mediated free radical polymerization
has also been extensively investigated to develop chitosan hydrogels. Zhou et al used a water
soluble (methacryloyloxy) ethyl carboxymethyl chitosan (MAOECECS) for the preparation of
photocrosslinkable hydrogels for tissue engineering applications. MAOECECS was synthesized
using Michael addition reaction between -NH2 group of chitosan with C=C of acrylate group.
Briefly, a solution of MAOECECS in water was prepared and mixed with the photoinitiator D2959. The solution was exposed to UV light of wavelength 320-480 nm for 15 min to obtain the
hydrogel. D-2959 was used as a photoinitiator due to its low cytotoxicity. SEM analysis showed a
spongy macroporous structure. Crosslinking density played a key role in determining the pore
structure of the hydrogel. Similarly, the swelling behavior of the hydrogel was dependent on the
concentration of MAOECECS. Degradation of the hydrogel in the presence of lysozyme can also
be modulated by varying the crosslinking density. Higher crosslinking density caused lower
degradation whereas lower crosslinking density showed higher degradation; lower crosslinking
makes the hydrogel more accessible for enzymatic attack as well as for enzyme penetration (73).
Arakawa et al prepared a photocrosslinkable hydrogel using methacrylated glycol chitosan
(MeGC) and collagen (Col). For the fabrication of the hydrogel, MeGC solution was prepared in
phosphate buffered saline (PBS). Col was added to the solution to form a semi-interpenetrating
network. Riboflavin was used as the photoinitiator for crosslinking. The hydrogel was formed
when the composite solution was exposed to visible blue light of wavelength 400-500 nm in the
presence of the photoinitiator. Use of visible light is more beneficial as it is less harmful, less
mutagenic, does not generate heat, and transmits deeper into the tissue. Gelation time decreased
with increase in riboflavin content. MeGC-Col hydrogel had a compressive strength of ~1.8 kPa,
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which is higher than that of MeGC gel. Higher compressive strength of the MeGC-Col hydrogel
has been attributed to the formation of a semi-interpenetrating network (76).

1.5.3.1. Biomedical applications
Using a photocrosslinkable chitosan hydrogel (Az-CS-LA), Tsuda et al demonstrated the
effective prevention of ectopic bone formation for up to 8 weeks in rat model with calvarium and
fibula defects. The hydrogels suppressed bone formation by forming granulated tissue in the defect
area (74). Fujitha et al synthesized a photocrosslinked chitosan (Az-CS-LA) hydrogel for
delivering fibroblast growth factor-2 (FGF-2) for treating chronic myocardial infarction in rabbit
model. Significant improvement in systolic pressure at the left ventricle was observed along with
increased angiogenesis and formation of viable myocaridium (77). Arakawa et al developed an
injectable photocrosslinked hydrogel from MeGC and Col as a delivery system for bone marrow
stromal cells (BMSCs) to support bone regeneration. The study showed that BMSCs showed
greater cellular attachment, proliferation and osteogenic differentiation in MeGC-Col hydrogel
when compared to MeGC hydrogel alone. Increased alkaline phosphate activity along with
mineralization in BMSCs indicated that MeGC-Col hydrogel had the ability to promote bone
regeneration (76). Horio et al prepared a blend of photocrosslinkable chitosan hydrogel mixed with
photocrosslinked chitosan sponges (PCSM-S) and used it for treating liver injury in rat model. In
vivo analysis in heparinized rats with penetrating wound confirmed that PCSM-S showed
increased hemostatic effect and had no adverse effects (78). Kim et al developed a
photocrosslinked hydrogel made of chitosan-lactide-fibrinogen (CLF) as a delivery system for
bone morphogenetic protein (BMP)-2 (79). Chitosan and lactide in the hydrogel controlled the
physiochemical properties of the hydrogel (80). Fibrinogen, which contains heparin-binding
domains, was added to this system to improve BMP-2 binding. The incorporation of growth factor17

binding ligands to the hydrogel was shown to maintain protein bioactivity and provide sustained
release of BMP-2 over a period of time. Efficiency of the hydrogel delivery system was evaluated
in vitro as well as in vivo in rat defect model. The results indicated increased cell viability, neoosteogenesis and bone healing; the responses were dependent on the dose of the growth factor
(79). To increase the bioactivity of chitosan-based hydrogels, Choi et al developed a
photocrosslinked MeGC hydrogel containing extracellular matrix (ECM) constituents such as
collagen II and chondroitin sulphate for cartilage repair. The hydrogel demonstrated the ability to
promote chondrogenesis and increase cell-matrix interactions (81). Rickett et al used a
photocrosslinked chitosan hydrogel conjugated with 4-azidobenzoic acid as an adhesive for
treating peripheral nerve anastomosis. Cell culture study revealed the hydrogel to be non-toxic
with excellent mechanical properties, qualities that are essential for an efficient bioadhesive (82).
Photocrosslinked collagen-chitosan hydrogels were used to design contractile cardiac tissue in
vitro. Microgrooves 10 µm, 20 µm and 100 µm in size were formed on the hydrogel using
polydimethylsiloxane (PDMS) molds. The cardiomyocytes showed oriented growth with respect
to the microgrooves in vitro. Electrical stimulations caused further alignment of the
cardiomyocytes. The study showed that cardiomyocytes seeded in three dimensional hydrogels
with smaller grooves (~10 µm) produced beating heart tissue in vitro, indicating the efficacy of
the smaller features in promoting cell-cell communication. Additionally, electrical stimulation
improved cell density and helped in attaining tissue morphology that could mimic the native tissue
upon implantation. Finally, biodegradability of the hydrogel could contribute towards translating
this engineered technique to clinical applications (83).
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1.5.4. Preparation of enzymatically crosslinked injectable chitosan hydrogels
Crosslinking of polymers to form hydrogels can be performed in the presence of enzymes.
This type of crosslinking is beneficial for in situ hydrogel formation because of the mild activity
of the enzymes (84). In situ hydrogel systems can be easily developed using enzyme-mediated
reaction as physiological pH and temperature are optimum for many enzymatic reactions. Enzymes
commonly used for crosslinking chitosan to form hydrogels are peroxidase (85), transglutaminase
(86) and tyrosinase (87).
Transglutaminase enzyme catalyzes the formation of isopeptide bond between glutamine’s
γ-amine group and the amine group of lysine. Transglutaminase is found in microbes and other
living organisms. Da Silva et al used microbial transglutaminase (mTGase) to crosslink chitosan
and gelatin for preparing hydrogel. The enzyme was used to form the bond between chitosan’s
glucosamine and gelatin’s glutamine. Chitosan was dissolved in acetic acid and gelatin was added
to prepare the chitosan-gelatin solution. Solution pH was kept at 5, where mTGase shows optimal
activity. Chemical crosslinking of chitosan and gelatin was performed at 37 oC by adding mTGase
in the concentration range of 10-40 enzymatic units depending on the amount of gelatin used.
Thermal deactivation of mTGase was then performed at 70 oC. Gelation time was found to be
dependent on mTGase concentration; the higher the enzyme concentration, the lower was the
gelation time. Mechanical property of the hydrogel was found to be dependent on the concentration
of chitosan and mTGase. Increase in chitosan concentration led to gels with higher moduli. Instead
of chemical crosslinking alone, physical-co-chemical gelation of the solution led to the formation
of homogenous gels with higher modulus and gel transparency (86).
Tyrosinase is an enzyme derived from both plants and animals (84). It is known to catalyze
the oxidation of phenol compounds containing tyrosine and other residues into o-quinones. Kang
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et al used tyrosinase enzyme for crosslinking chitosan and silk fibroin. Chitosan solution was
prepared by dissolving chitosan granules in water and adjusting the pH to 2 using hydrochloric
acid. Prior to crosslinking, pH of the chitosan solution was adjusted to 5-5.5, which is required for
tyrosinase activity. Silk fibroin solution was dissolved in a solution comprising of calcium
chloride, ethanol and water, followed by dialysis and filtration. Chitosan and silk fibroin solutions
were mixed together in different ratios and tyrosinase was added to the solution to initiate gelation.
Chemical crosslinking was confirmed using UV spectroscopy. The mechanism behind
crosslinking is that tyrosinase enzyme converts tyrosyl residues in silk fibroin to reactive oquinones. The amine group in the chitosan then reacts with the o-quinones in silk fibroin through
Michael addition reaction (87).
Horse radish peroxidase (HRP) enzyme is the most commonly used peroxidase enzyme for
enzymatic crosslinking. Peroxidase enzyme oxidizes phenols and generates free radicals that
mediate the crosslinking reaction. Sakai et al designed chitosan hydrogels using chitosan
conjugated with 3-(4-hydroxyphenyl) propionic acid (HPP) prepared via standard EDC coupling
reaction. The conjugated polymer showed limited solubility, so it was first dissolved in MES buffer
with a pH of 3.5. The pH was then adjusted to pH 7 by using 1 M sodium hydroxide. The hydrogels
were prepared by mixing the conjugated chitosan with HRP followed by chilled H2O2 solution.
Gelation time of the hydrogel was found to be dependent on many factors such as concentration
of HRP, H2O2, phenol groups present in the polymer, and temperature (85). Jin et al developed a
biodegradable injectable hydrogel prepared from chitosan-graft-glycolic acid (GA) and phloretic
acid (PA) using enzymatic crosslinking in the presence of HRP and H2O2 as scaffold for cartilage
regeneration. Briefly, the hydrogel was prepared by adding HRP and H2O2 to the CS-GA/PA
solution. CS-GA/PA concentration was shown to significantly affect the gelation time; increase in
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the polymer concentration from 1 to 3 wt% decreased the gelation time from 4 min to 10 s.
Similarly, water uptake by the hydrogel decreased with an increase in polymer concentration,
which has been attributed to the increase in crosslinking density at higher polymer concentrations.
The hydrogel also exhibited pH-dependent swelling behavior. Storage modulus of the hydrogel
was between 1.3 and 5.5 kPa for 1 and 2 wt% polymer solution. Thus, the study indicated that the
physiochemical and mechanical properties of the hydrogel could be tailored by varying the initial
polymer concentration (88). Gohil et al recently reported the feasibility of developing
enzymatically crosslinked injectable hydrogel using water soluble GC. GC modified with HPP
using EDC/NHS chemistry was treated with HRP and H2O2 to initiate oxidative coupling of the
phenol moieties. Similar to the previous study, the GC gel also showed an increase in storage
modulus with increasing polymer concentration. SEM analysis showed that the hydrogel had a
porous microstructure (89).

1.5.4.1. Biomedical applications
Chen et al used sulfated chitosan hydrogel prepared by enzymatic crosslinking for tissue
engineering application. Sulfated chitosan modified with HPP was crosslinked with HRP and
H2O2. In vitro test showed that the hydrogel had no cytotoxicity towards human umbilical vein
endothelial cells (HUVECs). In vivo test on animal model showed no thrombus formation and
good tissue compatibility showing its potential for tissue application (90). Jin et al used an
injectable chitosan hydrogel for cartilage application. Chondrocytes cultured in the hydrogel
showed cell viability and remained round for up to 2 weeks. The hydrogel also exhibited
biodegradability in the presence of lysozyme (88). In vitro study of the hydrogel prepared by Gohil
et al via enzymatic crosslinking of HPP-GC demonstrated excellent viability of encapsulated 7F2
osteoblast cells, demonstrating the hydrogel’s cytocompatibility (89). In vivo study was performed
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in Col3.6 transgenic fluorescent mice by creating bilateral critical size calvarial bone defect to
evaluate the efficacy of the gel to locally deliver BMP in a biologically active form. The study
showed that the hydrogels maintained bioactivity of recombinant BMP-2, supported cell-mediated
mineralization, and led to complete regeneration of critical size defect. (89). Although the study
showed the feasibility of developing an HPP-GC-based injectable system for growth factor
delivery, it had a few demerits. In vivo study showed that at even at 8 weeks (Figure 1.6), there
was a considerable residue of hydrogel present in the defect area. Another issue was the lack of
spreading of the encapsulated osteoblasts in the hydrogel despite their excellent viability.

Figure 1.6: Shows the hematoxylin-stained critical size defect after 8 weeks. ‘*’indicates nondegraded hydrogel (89)

1.6. Conclusion
Chitosan, which is a deacetylated derivative of chitin, is a versatile polymer with inherent
properties including biocompatibility, antimicrobial activity, mucoadhesivity, biodegradability
and low toxicity. It is extensively used for a wide range of biomedical applications like tissue
engineering and drug delivery. Chitosan polymer can be used for developing hydrogels via
physical and chemical crosslinking methods. Recent studies show the feasibility of forming
injectable hydrogels in situ. Injectable hydrogels are easy to handle, are minimally invasive, and
easily fill up the defect area. Injectable hydrogels can be of different types such as thermogelling,
pH-activated, photocrosslinked and enzymatically crosslinked. Enzyme-based crosslinking is
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generally considered mild, nontoxic and biocompatible. A previous study performed in our group
demonstrated the feasibility of developing injectable HPP-GC hydrogels that can be enzymatically
crosslinked using HRP and H2O2. The study showed the ability of the hydrogels to retain the
viability of encapsulated cells. Moreover, the hydrogels showed a unique advantage to locally
present bioactive molecules such as BMP in a highly active manner to support complete
regeneration of critical size calvarial model in a spatially controlled manner. The injectable system
however, presented some limitations. One of the limitations was the lack of degradation of the
matrix, which can adversely affect tissue regeneration. Another limitation was the lack of cell
spreading in the hydrogel, which may adversely affect the functions of adherent cells such as
osteoblasts. The studies described in Chapters 2-4 have been designed to address these two
limitations of enzymatically crosslinked HPP-GC hydrogels.

23

CHAPTER 2: DEVELOPMENT OF INJECTABLE HYDROGELS FROM
GLYCOL CHITOSAN AND ACETYLATED GLYCOL CHITOSAN

2.1. Introduction
2.1.1. Glycol chitosan
Glycol chitosan (GC) is a water soluble derivative of chitosan that contains a glycol
functional group at the site of the C-6 hydroxyl group (Figure 2.1). The glycol moiety is
responsible for the water soluble nature of this derivative and for retaining all the desired properties
of chitosan at the same time (89). GC can be prepared by reacting chitin with ethylene oxide and
then deacetylating the resulting polymer (91). GC maintains its amine group, which helps in further
modification of the polymer for different biomedical applications (92). Extensive research has
been carried out on GC in the last 10 years or so for various therapeutic applications such as growth
factor delivery (89), cell based therapies (92), nanoparticle carrier for anticancer drugs, peptides
(93), gene transfection (94), and as nanoprobes for cancer diagnosis (95).

Figure 2.1: Structure of glycol chitosan (91)

2.1.2. Literature review on glycol chitosan
Due to excellent water solubility, GC has been used in various forms such as hydrogels,
coatings, nanoparticles, and nanogels for biomedical applications. Various methods have been
investigated to crosslink GC to develop hydrogels and nanoparticles. Cao et al developed an in
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situ-crosslinked injectable GC hydrogel using multi-functionalized benzyaldehyde PEG analog
derivative for cartilage regeneration. In vitro study showed chondrocyte viability as well as
proliferation upon encapsulation in GC hydrogel. The hydrogel showed good biocompatibility as
demonstrated by an in vivo subcutaneous study. The hydrogel was present in vivo even after 12
weeks post-implantation. (96). Anna et al developed a cell delivery system based on
photocrosslinked MeGC for the delivery of pancreatic islets for the treatment of type 1 diabetes.
In the study, they first encapsulated the cells in calcium alginate beads and then coated the beads
with MeGC followed by photocrosslinking to form capsules. Coating alginate beads with MeGC
improved the swelling and biocompatibility properties of the beads. In vitro encapsulation study
demonstrated sustained and controlled release of insulin over a period of time as well as viability
of islet cells in MeGC-coated alginate beads. In vivo results showed the biocompatible nature of
the MeGC-coated alginate capsules when compared to alginate/poly-l-ornithine/alginate capsules
(92). Yoon et al used self-assembled amphiphilic GC-5β-cholanic acid-conjugated nanoparticles
as a delivery system for the treatment of cancer. The study demonstrated the feasibility of
encapsulating doxorubicin and Bcl-2 siRNA in GC nanoparticles. The in vivo study showed a
dose-dependent release of the drug from the nanoparticles and desirable biodistribution, factors
that are essential for cancer treatment (97). For siRNA delivery, Periera et al developed a selfassembled GC-based nanogel system that was synthesized by grafting hydrophobic chains. When
incubated with HeLa cells, the GC nanogel was detected on the surface of the cells and was nontoxic to the cells. Thus, the GC nanogel demonstrated the potential to be developed as a targetable
siRNA vehicle (98).
Our laboratory developed an enzymatically crosslinked injectable GC hydrogel as a cell
and growth factor delivery system for regenerative engineering application as discussed in section
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1.5.4.1. In vivo study was performed on Col3.6 transgenic fluorescent reporter mouse model.
Retention of bioactivity of recombinant human BMP-2 was observed in GC-based hydrogels in
bilateral critical size calvarial bone defects. The study demonstrated osteoinductivity of rhBMP-2,
as indicated by the presence of fluorescent osteoblast cells migrating to the defect area and by the
evidence of wound closure in 8 weeks (89). As discussed in Chapter 1, even though the
enzymatically crosslinked GC hydrogel showed good cytocompatibility and the ability to retain
the growth factors in the hydrogel in a bioactive form, the in vivo study demonstrated a lack of
degradation of the hydrogel, which limited the extent of tissue growth. The purpose of the study
discussed in this chapter is to further characterize the GC hydrogel and to evaluate the feasibility
of chemically modifying GC to increase its enzymatic degradability. This chapter focuses on the
sterilization of GC and the development of novel acetylated derivatives of enzymatically
crosslinked GC hydrogels for biomedical applications.

2.2. Materials and methods
2.2.1. Materials
The following items and chemicals were used for carrying out the experiments: GC (Sigma
Aldrich), morpholinoethanesulfonic acid (MES) powder (Fisher), N-3-dimethylaminopropyl-Nethyl carbodiimide hydrochloride (EDC) (Sigma Aldrich), N-hydroxysuccinimide (98%) (NHS)
(Sigma Aldrich), 3-(4-hydroxyphenyl) propionic acid (98%) (HPP) (Sigma Aldrich), horseradish
peroxidase (HRP) (Sigma Aldrich), hydrogen peroxide (Sigma Aldrich), acetic anhydride (Sigma
Aldrich), dialysis membrane (Spectra/por7), FITC-albumin (Sigma Aldrich), lysozyme from
chicken egg white (Sigma Aldrich), α-MEM media (colorless) (Life Technologies), U100 insulin
syringe (Becton Dickinson), LIVE/DEAD®

viability/cytotoxicity kit (Life Technologies),

deuterium oxide (Cambridge isotope laboratories, Inc) and 7F2 cells (ATCC CRL-12557).
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2.2.2. Preparation of HPP-modified glycol chitosan polymers
HPP modification was done on GC using carbodiimide-based coupling reaction. For
preparing a batch of HPP-modified GC (HPP-GC) polymers, 500 mg of GC was dissolved in 350
mL of 1 M MES solution (pH 5.5) by stirring at room temperature (RT) for 3 h. For HPP-coupling,
EDC (2.608 mmol) and NHS (2.172 mmol) were dissolved in 50 mL of 1 M MES solution for 5
min, followed by the addition of HPP (3.009 mmol) and reaction at RT for 1 h. This solution was
then added to the solution containing GC and kept for 24 h at RT. The final solution was then
dialyzed against water using dialysis tubings with cut-off size of 10,000 Da. Dialysis was carried
out for 3 days during which the water was changed 6 times. After dialysis, the solution was allowed
to freeze at -20oC. The frozen solution was then lyophilized for 3 days and stored at -20oC (89).

2.2.3. Sterilization of HPP-modified glycol chitosan polymers
The following different methods were used for sterilizing the HPP-GC solution:
a) Filtration: The lyophilized HPP-GC polymer was dissolved in MilliQ water and filtered using
membranes with pore sizes of 0.45 µm and 0.22 µm. The filtered solution was frozen at -20 oC
followed by lyophilization for 3 days.

b) UV: HPP-GC solution at a concentration of 20 mg/mL was prepared and an aliquot of 500 µL
was taken in a microcentifuge tube and exposed to UV-B light for 30 min.

c) Autoclaving: Two different methods were used. In the first method, 40 mg of lyophilized HPPGC polymer was autoclaved directly at 121 oC and 15 psi for 30 min. In the second method, 40
mg of lyophilized HPP-GC was dissolved in 2 mL of α-MEM at a concentration of 20 mg/mL.
The solution was then autoclaved at 121 oC and 15 psi for 30 min.
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2.2.4. Preparation of HPP-modified glycol chitosan hydrogels
HPP-GC polymer was dissolved in α-MEM at a concentration of 20 mg/mL. 20 units of
HRP was added to the solution and mixed uniformly. To prepare the hydrogel, enzymatic
crosslinking of the polymer solution containing HRP was done using H2O2 added at a
concentration of 7.34 mM. This procedure was followed for both sterilized as well as unsterilized
HPP-GC polymers.

2.2.5. Rheological characterization of HPP-modified glycol chitosan hydrogels
HPP-GC polymer was sterilized as described in section 2.2.3. 100 µL of the polymer
solution containing HRP was then enzymatically crosslinked in syringe molds as described in
section 2.2.4. Rheological properties of the sterilized, preformed HPP-GC hydrogel was
determined using Discovery HR3 hybrid rheometer (TA instruments), with parallel plate geometry
(12 mm), gap width of 600 µm, and frequency sweep from 0.1 to 100 rad s-1 at a strain of 5%.
Three hydrogel samples were tested for each polymer (n=3).

2.2.6. Acetylation of HPP-modified glycol chitosan polymers
The lyophilized HPP-GC polymer (from section 2.2.2) was used for making acetylated
HPP-GC polymer. 100 mg of lyophilized HPP-GC polymer was weighed out and first dissolved
in 2 mL of distilled water under stirring. To this, 4 mL of methanol was added and mixed well.
Acetic anhydride solution was prepared by adding acetic anhydride to 4 mL of methanol and
mixing thoroughly under the fume hood. The acetic anhydride solution was added dropwise to the
HPP-GC solution and allowed to react for 24 h under stirring. Different sets of acetylated polymers
were prepared and labeled as 0GC, 0.1GC, 0.2GC, 0.3GC, 0.5GC and 1GC, where the numbers
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represent the molar ratio of acetic anhydride added (Table 2.1) to amine groups present in
completely deacetylated GC (Appendix A1). Samples of 0GC, 0.1GC, 0.2GC and 0.3GC were
prepared using bench-top stirring. To ensure uniform mixing and to avoid gel formation during
mixing, overhead stirring method was used for samples of 0.5GC and 1GC. The sample was
purified using dialysis against water for 3 days with 6 changes of water. After dialysis, the solution
was frozen overnight at -20 oC, lyophilized for 3 days and then kept at -20oC for long term storage.

Table 2.1: Shows the amount of acetic anhydride used for different acetylated HPP-GC samples
Acetylated GC

Acetic anhydride
Volume

Moles

0GC

-

-

0.1GC

4.6 µL

48. 7 µmol

0.2GC

9.2 µL

97. 3 µmol

0.3GC

13.8 µL

146.0 µmol

0.5GC

23 µL

243.3 µmol

1GC

46 µL

487.3 µmol

2.2.7. Characterization of acetylated HPP-modified glycol chitosan polymers
2.2.7a. Attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR)
ATR-FTIR was performed using Nicolet iS10 spectrophotometer (Thermoscientific) with
SMART iTR diamond ATR accessory. Spectra for the different acetylated HPP-GC polymers were
obtained between wavenumbers of 400 and 4000 cm-1 at a resolution of 2 cm-1. 200 scans were
collected during each FTIR run.
2.2.7b. NMR
1

H-NMR was performed on the acetylated HPP-GC polymer using an 800 MHz Agilent

VNMRS spectrophotometer with a triple resonance HCN cold probe. Briefly, 5 mg of the
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acetylated HPP-GC polymer was dissolved in 0.5 mL of deuterium oxide. 1H-NMR spectra were
obtained using the following parameters: 68 oC, 8992.8 Hz bandwidth, 128 transients, and 90o flip
angle. Mnova software (Mestrelab Research, Spain) was used for analyzing the data. Three
different samples were analyzed for each polymer (n=3).

2.2.8. Preparation of acetylated HPP-modified glycol chitosan hydrogels
Acetylated HPP-GC polymer was dissolved in α-MEM at a concentration of 20 mg/mL.
20 units of HRP was added to the solution and mixed uniformly. To prepare the hydrogel,
enzymatic crosslinking of the polymer solution containing HRP was done using H2O2 added at a
concentration of 7.34 mM.

2.2.9. Swelling behavior of acetylated HPP-modified glycol chitosan hydrogels
The different acetylated HPP-GC hydrogels – 0GC, 0.1GC, 0.2GC, 0.3GC, 0.5GC and
1GC – were prepared in syringe molds as described in section 2.2.8. Four hydrogel samples were
tested for each polymer (n=4). Hydrogels prepared from 150 µL of the respective polymer
solutions were weighed in glass vials (Wsi) and incubated in PBS in a shaker at 37 oC. Weights of
the hydrogels with the vials were determined after removing excess PBS (Wsf) at days 1, 3, 5, 7
and 14. The PBS removed was replaced with fresh PBS after the measurement at each time point.
The swelling ratio was determined using the following equation [2]:

%Swelling 

Wsf  Wsi
Wsi
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 100      [2]

2.2.10. Protein release profile from acetylated HPP-modified glycol chitosan hydrogels
Hydrogels prepared from acetylated HPP-GC polymers – 0GC, 0.1GC, 0.3GC, 0.5GC and
1GC – were used for the protein release study. First, a stock solution with a polymer concentration
of 40 mg/mL was prepared in sterile water. For loaded samples, 1.5 mL of the polymer stock
solution was mixed with 0.75 mL of FITC-albumin stock solution (20 mg/mL), 0.75 mL of αMEM, and 60 units of HRP. For unloaded samples, 0.5 mL of the polymer stock solution was
mixed with 0.5 mL of α-MEM and 20 units of HRP. Disc-shaped hydrogel was then prepared by
mixing 162 µL of loaded or unloaded polymer solution in a syringe mold with H2O2. The H2O2
concentration in the final solution was 8.17 mM. Four hydrogel samples were tested for each
polymer (n=4). The loaded and unloaded hydrogel samples were then placed in 3 mL of i) 10
µg/mL lysozyme in PBS containing 1% Anti-Anti ii) 50 µg/mL lysozyme in PBS containing 1%
Anti-Anti and iii) PBS containing 1% Anti-Anti. The samples were then incubated in a shaker at
37 oC. At each time point, 1.5 mL of PBS with lysozyme or PBS alone were removed from each
sample and replaced with a fresh batch of the respective solutions. Time points used for the study
were: 1 h, 3 h, 16 h, 24 h, 38 h, 48 h, 72 h, 96 h, 120 h, and 144 h. FITC release was measured in
a plate reader at 495 nm. A standard curve was plotted using serial dilution of solution containing
400 µg/mL of FITC-albumin.

2.2.11. Viability and spreading of osteoblast cells encapsulated in acetylated HPP-modified glycol
chitosan hydrogels
For cytocompatability study, osteoblastic cell line 7F2 (derived from mouse bone marrow)
was used. Cells were grown and maintained in α-MEM (2 mM L-glutamine, 1 mM sodium
pyruvate, with no ribonucleosides and deoxyribonucleosides) with 10% horse serum and 1%
penicillin-streptomycin (pen-strep). The acetylated HPP-GC polymer was dissolved in α-MEM at
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a concentration of 20 mg/mL and sterilized under UV light for 30 min prior to the cell
encapsulation step. Cells were trypsinized and suspended in the acetylated HPP-GC polymer
solution with 20 units/mL of HRP at a cell density of 0.8 million/mL. 10 µL of polymer solution
containing HRP and cells was taken in a syringe mold and mixed with H2O2. The H2O2
concentration in the final solution was 7.34 mM. The hydrogel with encapsulated cells was
incubated in Costar® ultra-low attachment plate with media at 37 oC and 5% CO2. Media was
changed every 3 days to keep the cells healthy. At specific time points, the hydrogel with
encapsulated cells was transferred to MatTek glass-bottom 35 mm dish and stained using
LIVE/DEAD® viability/cytotoxicity kit for mammalian cells. Confocal microscopy imaging was
done using a Zeiss LSM 510 Meta microscope.

2.2.12. Statistical analysis
All results presented in the chapter are expressed as mean ± standard deviation. Statistical
analysis was done using One-way ANOVA followed by Student’s Newman-Keuls (SNK) test in
SigmaStat (ver 2.3). Statistical significance was set at p < 0.05.

2.3. Results and discussion
2.3.1. Synthesis of HPP-modified glycol chitosan and characterization of sterilization method for
regenerative application
HPP-GC was prepared using the method described by Gohil et al (89). HPP, which
contains the phenol group, was added to GC using standard carbodiimide chemistry. The
modification happens in two steps – i) EDC activates the carboxyl group of HPP, which leads to
the formation of an active intermediate called O-acylisourea ii) which then reacts with the primary
amine groups present in GC and forms HPP-GC. Incorporating the phenolic group in GC helps in
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developing an enzymatically crosslinked injectable hydrogel system that can gel in physiological
conditions (89). The HRP-catalyzed crosslinking of phenol-rich polymers is extensively
investigated due to the ability of the process to form hydrogels with desirable and tunable
properties (99). Figure 2.2 explains HPP addition to GC based on standard carbodiimide chemistry.

Figure 2.2: Schematic diagram of HPP-GC synthesis (89)

HPP-GC retains the excellent aqueous solubility of GC and can be dissolved in aqueous
media at physiological pH. Gohil et al used a 1:1 (v/v) solution of water and α-MEM (89). In order
to optimize the HPP-GC hydrogels for cell encapsulation, the HPP-GC polymer was dissolved in
α-MEM in the present study. To understand the effect of the dissolution media on the pH of the
HPP-GC solution, the pH of the solution at a concentration of 20 mg/mL was measured at RT.
The pH of HPP-GC dissolved in 1:1 solution of water and α-MEM was found to be 6.97 ± 0.045
and the pH of HPP-GC dissolved in α-MEM was found to be 7.12 ± 0.046. Based on the data, both
solutions showed neutral pH and hence may be acceptable for hydrogel preparation. However, for
the cell encapsulation study, dissolving HPP-GC in α-MEM may be more beneficial for providing
appropriate amount of nutrients.
Any biomaterial to be used for human implantation or any regenerative application must
be sterilized in order to avoid bacterial and fungal contamination (100). Since HPP-GC is
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developed as an injectable hydrogel, sterilization is very important before using it in biomedical
applications. Even though different sterilization methods are available, the mode of sterilization
has been shown to affect the physiochemical properties and functionality of polymeric materials
(101). Hence, selecting a suitable sterilization procedure that causes minimal variation in the
physiochemical and functional properties is essential. For biopolymer solutions, the most
commonly used sterilization methods include filter sterilization, UV sterilization (102) and
autoclaving. The effect of these different sterilization methods on HPP-GC was studied and the
best method was determined by testing gelation after the treatment and by comparing rheological
properties to those of unsterilized HPP-GC. The different methods tested for HPP-GC sterilization
are i) membrane filtration using 0.45 µm filter ii) membrane filtration using 0.22 µm filters iii)
UV-B sterilization of HPP-GC polymer solution iv) autoclaving the lyophilized HPP-GC powder
and autoclaving the HPP-GC polymer solution prepared in α-MEM. Figure 2.3 shows the
appearance of unsterilized and sterilized HPP-GCs.

Figure 2.3: (A) Untreated HPP-GC (B) Filtered (0.45 µm) and lyophilized HPP-GC (C) Filtered
(0.22 µm) and lyophilized HPP-GC (D) UV-sterilized HPP-GC solution (E) Autoclaved HPPGC powder (left) and autoclaved HPP-GC solution (right)

Figures 2.3B and C show HPP-GC solution filtered through filters with pores of size 0.45
µm and 0.22 µm. Filtering followed by lyophilization of the polymer solution did not significantly
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affect the appearance of the HPP-GC. Similarly, as seen in Figure 2.3D, the UV-sterilized polymer
solution did not show any change in its appearance as well.
However, autoclaving the HPP-GC powder and solution showed significant changes in
their properties. The autoclaving seemed to char the polymer (Figure 2.3E [left]). Autoclaving the
HPP-GC solution on the other hand led to the formation of an insoluble polymer film in the tube
(Figure 2.3E [right]). Based on these observations, it was concluded that autoclaving in powder
or solution form is not a feasible sterilization method for HPP-GC. The filter-sterilized and UVsterilized polymer solutions were further tested for gelation and rheological properties to identify
the most suitable sterilization process for the in vitro studies.
The sterilized samples were dissolved in α-MEM at a concentration of 20 mg/mL.
Appropriate volume of HRP was added to the solution to adjust its concentration to 20 units/mL.
Enzymatically crosslinked hydrogel was formed by the addition of H2O2 to the HPP-GC/HRP
solution. The H2O2 concentration in the final solution was 7.34 mM. The gelation process is
mediated by the reaction of heme group present in HRP with H2O2, forming a complex of
porphyrin-based cationic radical and oxoferryl center. The complex formed then acts as a reducing
agent and gets oxidized by reacting with the phenolic oxidizing agent. Thereafter, the two phenolic
radicals react to form a covalently crosslinked network. Crosslinking can be of two types – i) C-C
covalent bond between aromatic rings of ortho-carbon groups or ii) C-O bond between phenolic
oxygen and ortho-carbon of aromatic ring (89).
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Figure 2.4: Schematic representation of enzymatic crosslinking in HPP-GC hydrogel (89)

For testing gelation, 200 µL of sterilized polymer solution containing HRP was gelled in a
glass vial by adding H2O2. Hydrogel formation was confirmed by the vial inversion method.
Unsterilized HPP-GC was used as the control. MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5diphenyltetrazolium bromide] was added to impart color to the solution for better visualization of
gel formation. As shown in Figure 2.5, all sterilized samples showed gelation within 1 min similar
to the unsterilized sample accompanied by some water loss (synersis). The data demonstrate the
potential of all the sterilized samples to undergo gelation under the standard conditions.
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Figure 2.5: Left side shows free-flowing polymer solution and right side shows corresponding
hydrogel formation on addition of HRP and H2O2 (A) HPP-GC (B) Filter-sterilized HPP-GC
(0.45 µm) (C) Filter-sterilized HPP-GC (0.22 µm) (D) UV-sterilized HPP-GC

Further characterization of the sterilized samples was performed by following the
rheological behavior of the gels. Frequency sweep was performed on the preformed hydrogels with
5% strain. Figure 2.6 shows the storage modulus of the preformed gels prepared from solutions
sterilized by different methods. Storage modulus of unsterilized HPP-GC hydrogel was found to
be 890.89 ± 78.69 Pa, whereas hydrogel formed from HPP-GC solution filtered using 0.45 µm
filter showed a modulus of 195.33 ± 10.41 Pa and that formed from HPP-GC solution filtered
using 0.22 µm filter showed a modulus of 183.69 ± 19.82 Pa. This shows the significant decrease
in modulus of hydrogels formed from filtered HPP-GC solution compared to that formed from the
unfiltered solution. One potential reason for the lower moduli of the filtered hydrogels is due to
the loss of high-molecular weight polymer during the filtration process. The hydrogel prepared
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from the UV-sterilized polymer solution on the other hand showed a modulus of 656.71 ± 46.84
Pa, which is significantly higher than that observed with the filter-sterilized solutions. However,
as shown in the Figure 2.6, the UV-sterilized solution also showed a decrease in gel modulus
compared to the unsterilized solution, indicating the possibility of some polymer degradation
during the process. Based on these data, it was concluded that among the tested methods, UV
sterilization is the best method to sterilize HPP-GC without significantly affecting its physical,
mechanical and gelation properties.

Figure 2.6: Rheological characterization of unsterilized and sterilized HPP-GC. Graph shows the
storage modulus obtained by frequency sweep of corresponding hydrogel. Data are expressed as
mean ± standard deviation with n=3. One way ANOVA followed by SNK test; p*** < 0.001 vs.
all other groups, p### < 0.001 vs. all other groups
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2.3.2. Synthesis and characterization of acetylated HPP-modified glycol chitosan
Acetylated HPP-GC polymer was prepared by reacting HPP-GC with acetic anhydride as
discussed in section 2.2.6. Figure 2.7 shows the schematic indicating the preparation, acetylation
and enzymatic crosslinking of HPP-GC.

Figure 2.7: Schematic showing HPP modification of GC using carbodiimide-mediated coupling
and followed by acetylation of HPP-GC

The addition of acetic anhydride causes selective N-acetylation in chitosan and is the most
commonly used method for increasing the degree of acetylation (DA). The acetic anhydride-based
method produces no toxic by-products and, being a mild reaction, helps in retaining and preserving
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the inherent biological properties of the polymer. By varying the DA in chitosan, many properties
such as biocompatibility, mechanical strength and biodegradability can be tuned (103). Different
techniques are used for determining degree of deacetylation (DDA) of chitosan, including titration,
FTIR, UV/Vis spectroscopy and 1H-NMR (104).
ATR-FTIR spectra for the different acetylated HPP-GC polymers are given Figure 2.8. The
spectra show all the characteristic peaks corresponding to GC as reported in the literature (89). In
addition, the spectra of all acetylated HPP-GC polymers show a carbonyl peak at 1653 cm-1, which
is in agreement with spectra reported for acetylated chitosan (89, 105) The peak can be attributed
to the C=O group of the amide formed upon acetylation. Increasing intensity of the peak with
increase in acetic anhydride content demonstrates the increasing degree of acetylation going from
0GC to 1GC.

Figure 2.8: ATR-FTIR spectra of different acetylated HPP-GC polymers
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Unlike FTIR, 1H-NMR can be used to quantitatively determine the extent of acetylation by
integrating the different proton peaks. Moreover, 1H-NMR gives the most accurate and precise
measurements for higher DDA as compared to the other methods. The acetylated HPP-GC
polymers were characterized using 1H-NMR and Figure 2.9 shows a representative 1H-NMR
spectrum of acetylated HPP-GC.

Figure 2.9: Representative 1H-NMR spectrum for acetylated HPP-GC

Percentage DDA value was calculated by finding the integrals of the different proton peaks.
The reference peak used was trimethyl silane (TMS), which is indicated in the spectrum. Baseline
correction for all the samples was done using the Bernstein correction method. The incorporation
of HPP in the polymer is indicated by the two corner peaks near 7 ppm. HOD indicates the solvent
proton corresponding to deuterium oxide, which was used for dissolving HPP-GC for the NMR
analysis. H1D and H2D correspond to the deacetylated monomer, HAc corresponds to the acetyl
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group, and H3 to H6 correspond to the proton peaks. The equations [3] and [4] used for finding
the percentage DDA value were as described by Hirai et al (106).

1
( HAc )
DDA%  [1  3
]  100      [3]
1
( H 2  6)
6
DA%  100  DDA%      [4]
(Where H2–6 denotes the sum of integrals of the peaks H2, H3, H4, H5, H6 and H6΄)

Table 2.2 shows the percentage DA values obtained for the different acetylated HPP-GC polymers.
It can be seen that DA increases with increasing acetic anhydride concentration (going from 0GC
to 1GC), demonstrating the dose-dependent increase in acetylation of the polymer.

Table 2.2: Percentage DDA and DA of HPP-GC as determined by NMR
Sample

DDA%

DA%

0GC

92.51 ± 0.54

7.48 ± 0.54

0.1GC

83.65 ± 1.99

16.35 ± 1.99

0.2GC

75.35 ± 3.86

24.65 ± 3.86

0.3GC

71.97 ± 0.63

28.03 ± 0.63

0.5GC

68.30 ± 1.08

31.70 ± 1.08

1GC

64.63 ± 0.69

35.36 ± 0.69

2.3.3. Gelation of acetylated HPP-modified glycol chitosan
Similar to HPP-GC polymers, acetylated HPP-GC polymers also showed gelation in less
than 1 min accompanied by synersis (Figure 2.10). The data demonstrate that acetylation does not
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significantly affect the HRP-mediated gelation process of HPP-GC in the presence of H2O2. The
mechanism of gelation of acetylated HPP-GC is similar to that for HPP-GC (section 2.3.1).

Figure 2.10: Left side shows free-flowing polymer solution and right side shows corresponding
hydrogel formation on addition of HRP and H2O2 (A) 0GC before and after gelation (B) 0.1GC
before and after gelation (C) 0.2GC before and after gelation (D) 0.3GC before and after gelation
(E) 0.5GC before and after gelation (F) 1GC before and after gelation

2.3.4. Swelling behavior of acetylated HPP-modified glycol chitosan
Figure 2.11 shows the swelling behavior of the different acetylated HPP-GC hydrogels in
PBS with respect to time. Table 2.3 presents the associated statistical analysis and Figure 2.12
shows a photograph of the different hydrogels at the end of the swelling test, with freshly prepared
1GC hydrogel for comparison.
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Figure 2.11: Swelling behavior of the acetylated HPP-GC hydrogels. Data are expressed as
mean ± standard deviation with n = 4. One way Anova followed by SNK test comparing
different time points within the same group. Table 2.3 shows details of the statistical analysis
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Table 2.3: Statistical analysis for the acetylated HPP-GC hydrogels (Figure 2.11)
A 0GC

p*** < 0.001 vs. days 1, 3, 5, 7, 14, p### < 0.001 vs. days 3, 5, 7, 14

B 0.1GC

p*** < 0.001 vs. days 1, 3, 5, 7, 14, p# < 0.05 vs. days 7, 14

C 0.2GC

p** < 0.01 vs. days 3, 7, 14, p* < 0.05 vs. day 5, p# < 0.05 vs. days 7, 14

D 0.3GC

p*** < 0.001 vs. days 1, 3, 5, 7, 14, p### < 0.001 vs. days 7, 14, p## < 0.01 vs. days
3, 5, p^^^ < 0.01 vs. day 14, p$$$ < 0.001 vs. day 14, p&& < 0.01 vs. day 14

E

0.5GC

p***<0.001 vs. days 1, 3, 5, 7, 14

F

1GC

p*** < 0.001 vs. days 1, 3, 5, 7, 14, p### <0.001 vs day 14, p## < 0,01 vs day 7,
p# < 0.05 vs day 5, p^^ < 0.01 vs. days 7, 14 , p^ < 0.05 vs. day 5

Figure 2.12: Acetylated HPP-GC hydrogels after 14 days of swelling

Swelling of the hydrogel is indicative of its ability to take up water under given conditions.
Swelling properties of hydrogels depend on different factors including crosslinking density,
solvent nature, temperature and pH of the solvent. However, previous studies using HPP-GC
showed a decrease in weight of the hydrogels upon incubation in PBS at 37 oC (107). So, a study
was undertaken to understand the swelling behavior of acetylated HPP-GC hydrogels upon
incubation in PBS at 37 oC. As mentioned earlier, HPP-GC and acetylated HPP-GC hydrogels
were prepared from 20 mg/mL polymer solutions containing 20 units of HRP/mL and 7.34 mM
H2O2. As indicated by Figures 2.11 and 2.12, all acetylated HPP-GC hydrogels showed decrease
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in gel weight upon incubation in PBS at 37 oC. As shown in Figure 2.11, a significant decrease in
weight was observed in all the hydrogels by day 3. One potential reason is the increase in
crosslinking density of the hydrogel with time at the concentration of HRP and H2O2 used in the
present study. This is evident from the visual shrinking of the gel, indicating potential synersis
with time. A previous study demonstrated that an increase in crosslinking density resulted in
decrease in swelling ratio of the hydrogels. Using poly(L-glutamic acid) grafted with tyramine and
PEG, the study demonstrated a decrease in the equilibrium swelling ratio of the hydrogels with
increasing HRP and H2O2 concentrations (108). Our data demonstrate that acetylation did not
significantly affect the swelling behavior of the HPP-GC hydrogels. Further studies based on our
results can be focused on varying HRP and H2O2 concentrations in order to optimize the extent of
crosslinking to modulate hydrogel behavior.

2.3.5. Protein release profile from acetylated HPP-modified glycol chitosan hydrogels
Biodegradable injectable hydrogels are investigated as drug reservoir systems that can
provide controlled release of bioactive agents and proteins in a sustained manner. The efficacy of
acetylated HPP-GC hydrogels to serve as protein delivery vehicle was evaluated using bovine
serum albumin (BSA) as a model protein. In the present study, FITC-labeled BSA was used for
ease of quantification. As discussed in section 1.4, chitosan is susceptible to degradation in the
presence of lysozyme.
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Figure 2.13: In vitro studies showing the release of FITC-albumin under different conditions
A) PBS alone B) 10µg lysozyme in PBS and C) 50µg lysozyme in PBS (n=4)
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Figure 2.13A shows the extent of release of BSA from various acetylated HPP-GC
hydrogels incubated in PBS alone. All the hydrogels showed similar release profile irrespective of
the extent of acetylation, with the final percentage release being between 7 and 20%. More
importantly, the hydrogels showed very low release of the protein even after 6 days of incubation
in PBS at 37 oC. The data indicate significant binding of the protein to the HPP-GC hydrogel
irrespective of the degree of acetylation. Our previous study using alginic acid and hyaluronic acid
(109) showed similar retention of BSA in these enzymatically crosslinked hydrogels. Albumin is
a globular protein with several tyrosine residues and the FITC molecule also contains a phenol
functional group. So, in the present study, there is a possibility that the phenol groups present in
albumin are reacting with the phenol groups of HPP-GC and the protein is chemically conjugated
to the gel matrix, resulting in the very low release of the protein.
Hence, another study was performed to understand whether degradation of the hydrogel
could lead to the release of the bound protein in the gel. Since acetylated HPP-GC retains the bonds
that are sensitive to the enzyme, it is possible that acetylated HPP-GC hydrogels will undergo
degradation in the presence of lysozyme. So, the release study was performed by incubating the
FITC-albumin-loaded acetylated HPP-GC hydrogels in 10 and 50 µg/mL of lysozyme-containing
PBS at 37 oC. Figures 2.13B and C show the cumulative release of FITC-albumin from the
hydrogels into lysozyme-containing media as a function of time. As can be seen, the presence of
lysozyme made a significant difference to the release profile of the protein from the hydrogels. In
the presence of 10 µg lysozyme, the 0GC hydrogel did not show significant release of FITCalbumin and showed similar release profile to that in PBS alone. However, 0.1GC showed a
maximum release of FITC-albumin of ~37.27% at day 6. The 0.3GC hydrogel showed a maximum
release of ~67.45% at day 6, while 0.5GC hydrogel exhibited a maximum release of ~91.93% at
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day 6. The 1GC hydrogel showed complete release (~100%) at day 3. In the presence of 50 µg
lysozyme, the 0GC hydrogel showed a release profile similar to that in PBS alone and PBS
containing 10µg lysozyme. The 0.1GC hydrogel showed a maximum release of ~84.28% at day 6,
while 0.3GC showed a higher release of ~87.70% at day 6. The 0.5GC hydrogel showed a
maximum release of ~88.86% at day 4. The 1GC hydrogel showed fast release with a maximum
release value of about ~97.97% in 38 h. Thus, an increase in protein release was observed with an
increase in the concentration of lysozyme in the case of acetylated HPP-GC hydrogels but not in
the case of the 0GC hydrogel.
The data demonstrate that in the presence of lysozyme, the release of protein from the
hydrogel is highly dependent on degradation. Moreover, the concentration of lysozyme also plays
a key role in the extent of release, presumably by modulating the rate of hydrogel degradation.
This supports the possibility that the protein was bound to the gel and that gel degradation led to
protein release. Since lysozyme is present in human body, these hydrogels can serve as a platform
to develop delivery systems with tunable release profile based on the degree of acetylation of the
polymer

2.3.6. Viability and spreading of osteoblast cells in encapsulated acetylated HPP-modified glycol
chitosan hydrogels
Biopolymers are highly biocompatible and the mild enzymatic process makes them
attractive candidates as protein and cell delivery vehicles. One of the disadvantages in using
polysaccharide-based hydrogels for cell delivery is the lack of cell-adhesive groups in the polymer
that can support adhesion and spreading of encapsulated cells. Our previous studies using
enzymatically crosslinked alginic acid, hyaluronic acid (109) as well as HPP-GC hydrogels (89)
showed the feasibility of encapsulating the cells and retaining their viability. However, the
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encapsulated cells did not show spreading within the hydrogel matrix. So, a study was performed
to understand the effect of acetylation on the cellular compatibility of HPP-GC hydrogels.
One of the challenges observed in terms of culturing cells in acetylated GC was the fast
degradation of the hydrogels when incubated in cell culture media containing fetal bovine serum
(FBS). Table 2.4 shows the behavior of acetylated HPP-GC hydrogels upon incubation in media
containing FBS. The data clearly show that all the acetylated HPP-GC hydrogels underwent fast
degradation in the presence of FBS. In addition to lysozyme, chitosan is known to be degradable
in the presence of an enzyme called “chitinase”. Like lysozyme chitinase also acts on the acetyl
groups for initiating degradation. It has been reported that high level of chitinase enzyme is present
in the serum of cow, hen, sheep and goat. However, chitinase enzyme activity is not present in the
serum of horse, human, rabbit, hamster, guinea pig and cat (110). Horse serum has therefore been
used previously for studies involving acetylated chitosan (103). Another study was therefore
performed by incubating the most degradable acetylated HPP-GC (1GC) in media containing horse
serum. As shown in table 2.5, the hydrogel remained intact after 8 days, thereby showing the
stability of acetylated HPP-GC in horse serum.
Table 2.4: Hydrogel integrity optimization in FBS containing media at day 8
Acetylated

FBS alone

Media alone

Hydrogels

Media + 10%

Media + 5 %

Media + 2 %

FBS

FBS

FBS

0GC

Intact

Intact

Intact

Intact

Intact

0.1GC

Degraded

Intact

Degraded

Degraded

Intact

0.3GC

Degraded

Intact

Degraded

Degraded

Degraded

0.5GC

Degraded

Intact

Degraded

Degraded

Degraded

1GC

Degraded

Intact

Degraded

Degraded

Degraded
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Table 2.5: Hydrogel integrity optimization in media containing horse serum at day 8
Acetylated

Horse serum

α-MEM Media

10% horse

5% horse

2% horse

Hydrogel

alone

alone

serum in

serum in

serum in

media

media

media

Intact

Intact

Intact

1GC

Intact

Intact

7F2 osteoblast cells were used for the study. The acetylated HPP-GC hydrogel with
encapsulated cells was incubated in low cell-attachment plate to prevent cell adhesion on the tissue
culture plate. Prior to confocal imaging, the hydrogel was transferred to glass bottom dish for
imaging. Cell spreading and viability was assessed using LIVE DEAD® staining. Figure 2.14
shows the confocal images of cells in the hydrogels at days 7 and 14 post-encapsulation. As can
be seen from the presence of green fluorescence and absence of red fluorescence, the encapsulated
cells in all the hydrogels maintained their viability at both days 7 and 14, demonstrating the
excellent cytocompatibility of the hydrogels. However, none of the hydrogels investigated
supported cellular spreading upon encapsulation, demonstrating the need to further modify the gel
to support greater attachment and spreading of osteoblast cells.
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Figure 2.14: Confocal image showing viability of 7F2 osteoblast cells encapsulated in acetylated
HPP-GC hydrogels (20x)
52

2.4. Conclusion
The study demonstrated the feasibility of developing injectable enzymatically crosslinked
hydrogels from acetylated HPP-GC similar to HPP-GC. Among the different sterilization methods
tested for sterilizing the HPP-GC solution, UV sterilization showed least the effect on the polymer
and the corresponding hydrogel properties. The extent of acetylation of HPP-GC polymer prepared
by reacting it with acetic anhydride was determined by FTIR and 1H NMR. Irrespective of the
extent of acetylation, all the hydrogels showed fast gelation (< 1 min). The swelling behavior of
acetylated HPP-GC hydrogels in PBS was similar to that of HPP-GC hydrogels. Significant
decrease in weight was observed by day 3, presumably due to an increase in the crosslinking
density of the hydrogel with time. The release study in PBS alone demonstrated the ability of the
hydrogels, irrespective of the degree of acetylation, to retain the encapsulated protein within the
gel. However, in the presence of lysozyme, sustained release of protein from the hydrogel was
observed depending on the extent of acetylation. The higher protein release observed in HPP-GC
hydrogels with higher acetyl content is attributed to higher degradation of the hydrogels in the
presence of lysozyme. Finally, the cell encapsulation study demonstrated excellent in vitro
cytocompatibility of the hydrogels irrespective of the acetyl content. However, the encapsulated
cells remain round without any spreading even after 14 days in culture.
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CHAPTER 3: EVALUATION OF THE IN VIVO DEGRADATION OF
ACETYLATED HPP-GC HYDROGELS USING MOUSE
SUBCUTANEOUS MODEL

3.1. Introduction
3.1.1. Subcutaneous implantation
Degradable biomaterials are in increasing demand for developing therapeutic vehicles for
regenerative applications. Ideally, the degradable biomaterial should be non-toxic, should possess
a long shelf life, and should not trigger a strong immune response. The degradation should also be
parallel to the regenerative process. In vivo degradation of the biomaterial happens in the presence
of enzymes or by hydrolytic cleavage of the polymers. Mostly, natural polymers undergo
enzymatic degradation, the rate of which depends on various factors such as implant site of the
polymer, presence of the enzymes at the implant site, enzyme concentration, and chemical
modification of the polymer (111). As mentioned in chapters 1 and 2, chitosan degradation is
mediated by the action of the enzymes, lysozyme and chitinase (112). The degradation of chitosan
increases with the degree of acetylation of the polymer because lysozyme identifies and targets
acetyl residues. Lysozyme is present in the human body particularly in body fluids such as tears,
serum and saliva. Moreover, injury or surgical procedure can lead to acute inflammation resulting
in the production of lysozyme secreted mostly by neutrophils and macrophages. This can
significantly affect the degradation of the implanted natural polymer scaffolds (113, 114). In
addition to lysozymes, chitinase has been reported to show enzymatic activity on both chitosan
and chitin. Chitinase activity also depends on the acetylation of chitosan as it requires β-(1, 4)linked N-acetylglucosamine at the subsite for the catalytic cleavage (112). However, the presence
of chitinase in human beings is associated only with disorders like infection, asthama and allergy
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(115) (116). Therefore, lysozyme will be the main enzyme for the degradation of acetylated
polymers in the human body.

3.1.2. Literature review
Azab et al has conducted a study on rat to evaluate the biocompatibility and
biodegradability of chitosan hydrogels crosslinked with glutaraldehyde for the application of
brachytherapy. For the study, they implanted slow-degrading and fast-degrading hydrogels
subcutaneously and intraperitoneally. The study showed that the hydrogels were degraded by a
process mediated by lysozyme. Neutrophils released oxidants at the implant site. The oxidants
influenced lysozyme activity, which was responsible for the degradation of the hydrogels. The
degraded products were then cleared from the implant site through ingestion by macrophages.
Histological evaluation showed a milder response than typical foreign body response when
compared to ‘Vicril®’ (absorbable sutures) used for the surgery. The study also showed that the
hydrogel was not detected in any body organ and did not cause any tissue damage. It was reported
as a safe and biocompatible device for the delivery of radioisotopes for brachytherapy (117). Pinto
et al performed an in vivo evaluation of chitosan-poly (butylene succinate) fiber mesh by
subcutaneous implantation. The tissue response to the scaffold was evaluated using histological
and immunohistochemistry methods. The implants elicited normal immune response with a
cascade of events; at first, the neutrophils appeared on the implant site, which was followed by
macrophages and lymphocytes in the later phases. By week 12, the in vivo degradation became
profound, which was evident by the presence of host cells and the separation of the strands of the
fiber mesh (118). Vandevord et al studied the biocompatibility of porous chitosan scaffold in
mouse model via subcutaneous implantation. The study revealed that there was less inflammatory
response in the implant area. Histological analysis suggested neutrophil accumulation in the
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implant area that disappeared over time. Collagen was deposited in the pore spaces of chitosan.
Overall, the study suggested that chitosan had biocompatibility and could be used for regenerative
applications (119). Tomihata et al evaluated the degradation of deacetylated chitin-derived films
in vivo via subcutaneous implantation. The study showed higher biodegradation rate for chitin and
68.8 mol% deacetylated chitin and slower degradation rate for 73.3 mol% deacetylated chitin.
Despite the presence of cationic primary amine group in chitin and deacetylated chitin, the
materials showed milder tissue reaction (120).
The studies discussed above suggest that acetylation of chitosan can significantly increase
the in vivo degradation of the polymer. However, the effect of acetylation on the degradation of
HPP-GC hydrogels has not been investigated. The focus of this chapter is to evaluate the in vivo
biodegradability of acetylated HPP-GC hydrogels as a function of time.

3.2. Materials and methods
3.2.1. Materials
The following items and chemicals were used for carrying out the experiments: filtersterilized HRP (Sigma Aldrich), filter-sterilized hydrogen peroxide (Sigma Aldrich), α-MEM
(colorless) (Life Technologies), dialysis membrane (Spectra/por7), isoflurane (Phoenix),
buprenorphine, U100 insulin syringe (Becton Dickinson), and xylene (Fisher).

3.2.2. Enzymatically crosslinked acetylated HPP-modified glycol chitosan hydrogels
Acetylated HPP-GCs (0GC, 0.1 GC, 0.2GC, 0.3GC, 0.5GC and 1GC) were prepared as
described in section 2.2.8. The polymers were dissolved in α-MEM at a concentration of 20
mg/mL. 20 units of HRP (filter-sterilized) was added to the solution and mixed uniformly. The
hydrogels were prepared in syringe molds. 30 µL of polymer solution containing HRP was mixed
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with H2O2 (filter-sterilized) at a final concentration of 7.34 mM, which resulted in the formation
disc-shaped hydrogels.

3.2.3. Subcutaneous implantation of hydrogels in mouse model
Subcutaneous implantation was performed on BALB/C mice. Briefly, the mouse was
anesthetized using 1.75% isoflurane. Dorsal surface of the animal was shaved using automated
shaving razor (Peanut WAHL®). Then, the skin was dabbed with 75% ethanol wipes. Four
incisions were made on the dorsal region of the mouse to make a pouch. 30 µL of hydrogel was
prepared as described in section 3.2.2 in a 1 mL syringe mold and inserted into each pouch. The
skin was then closed using 5-0 VICRYL® sutures. Post-surgery, buprenorphine was injected into
the mouse based on its bodyweight. Based on a pilot study, different end points were selected for
hydrogels with varying degree of acetylation. Table 3.1 shows the predetermined time points at
which the animals were sacrificed by CO2 asphyxiation. The subcutaneous skin tissue with the
hydrogel samples were then collected for histology. Hydrogel alone was collected for SEM.
Table 3.1: Time points used for the subcutaneous implantation study
Acetylated
polymer

1 week

2 weeks

4 weeks

6 weeks

0GC *

+

+

+

+

0.1GC*

+

+

+

+

0.2GC*

+

+

+

+

0.3GC*

+

+

+

-

0.5GC*

+

+

+

-

1.0GC*

+

+

-

-

Sham#

+

+

+

+

(*2 mice at each time point, #1 mouse at each time point, + time point, - no time point)
(n = 2 samples for SEM and n = 6 samples for histology)
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3.3.4. Hematoxylin and eosin (H&E) staining of subcutaneous hydrogel implants
The subcutaneous skin tissue with the hydrogel was fixed in 10% formalin for 1 day. The
fixed tissue was then transferred to 30% sucrose solution prepared in PBS (pH 7.4) for 2 h. The
tissue sample was placed in a plastic mold (Fisherband® disposable base molds) and embedded
using Shandon CryomatrixTM (Thermoscientific) by placing it in dry ice. The sample was then
stored in plastic bags at -80oC until it was used for cryosectioning. 7 µm cryosections were
obtained by sectioning using a disposable steel blade (MX35 Premier+ Thermoscientific) on a
cryostat (Leica CM 3050S). The cryosections were obtained using tape (Cryofilm type IIC [10]
section – Lab Co.) transfer method and placed on glass slides (Superfrost®Plus microscopic slides
[Fisherband®]). The cryosections were then transferred to clean slides smeared with adhesive
(Norland optical adhesive 61) and kept at 4 oC overnight followed by UV curing for 7 min. The
samples were stored at 4 oC until H&E staining.

H&E staining: Slides containing the cryosections were incubated in 70% ethanol for 10
min. The slides were then kept in PBS for 10 min and then in water for 2 min. The slides were
then dipped in Mayer’s modified hematoxyline (Polyscientific R&D Corp.) for 2 min followed by
washes in double distilled water and then in ShandonTM bluing reagent (ThermoscientificTM) and
then again in double distilled water. Following this, the slides were dipped in ShandonTM Eosin-Y
(Thermoscientific) for 1 min and then again washed in double distilled water for 10 s. The slides
were then serially dipped in 70%, 90% and thrice in 100% ethanol. Finally, the slides were dipped
thrice for a minute each time in 100% xylene. This was followed by smearing of ShandonTM mount
toluene on the slide with a cover slip. The slides were then imaged using Axion Scan Z1 (ZEISS).
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3.3.5. SEM imaging
The hydrogel samples separated from skin tissue were collected in PBS (pH 7.4). PBS was
then removed and the sample was stored at -20oC followed by lyophilization. The lyophilized
hydrogels were cut using thin disposable scalpel blades and placed on die-cut carbon-conductive
double-sided adhesive disc (SPI supplies) attached on an aluminum stub. Before imaging, the
samples were platinum-coated for improved electrical conductivity. Imaging was done using a
JEOL 6335 Field Emission SEM. Operating parameters used for the imaging were 10 kV
accelerating voltage and 12 µA beam current.

3.3. Results and discussion
3.3.1. Surgery
In order to study the biodegradability of acetylated HPP-GC hydrogels, subcutaneous
implantation was performed in male BALB/c mice 10-11 weeks old. Figure 3.1 shows a detailed
representation of the subcutaneous implantation surgery. After the surgery, the hydrogels appeared
as small round protrusions outside the skin, which indicated that the preformed hydrogels that were
inserted remained intact.
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Figure 3.1: Shows the different steps involved in the surgery for subcutaneous implantation of
acetylated HPP-GC hydrogels (A) BALB/c mouse anesthetized using 1.75% isoflurane and
dorsal side shaved (B) Incisions made on dorsal region of mouse for making a pouch (C) 30 µL
hydrogels prepared in syringe mold (D) Insertion of hydrogel into the dorsal pouch (E), (G), (F)
and (H) Closing of the skin pouch using 5-0 VICRYL® sutures (I) Subcutaneous implantation of
four hydrogels in the mouse; areas are indicated by ‘*’

3.3.2. Subcutaneously degraded hydrogel implants
The mice remained in good health for the duration of the study. The skin incision that was
made to insert the hydrogels healed normally. Figure 3.2 shows the skin tissue with the hydrogel
collected at the predetermined time points. Macroscopic examination of the implants indicated that
the hydrogel degraded over a period of time depending on the degree of acetylation of the polymer.
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The higher the degree of acetylation, the faster the hydrogel degraded and disappeared in vivo. The
samples were analyzed further using H&E staining and SEM imaging.

Figure 3.2: Photographs of acetylated HPP-GC hydrogel implants obtained from BALB/C mice
at different time points – week 1, week 2, week 4 and week 6. ‘*’ indicates the location of the
hydrogel in the skin tissue
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3.3.3. SEM imaging and histological evaluation of subcutaneously degrading hydrogel implants
To obtain the gross morphology of the implants at predetermined times after subcutaneous
implantation, SEM imaging was performed on the isolated samples. Figures 3.3a and b show the
SEM images of the explanted hydrogels along with the surrounding fibrous tissue at various time
points post-implantation. At week 1, all the polymers (0GC, 0.1GC, 0.2GC, 0.3GC and 0.5GC)
except 1GC showed intact hydrogel at the implanted site surrounded by a fibrous sheath as shown
in the figure. The explanted and lyophilized hydrogels showed a porous structure similar to that
reported previously for lyophilized HPP-GC hydrogel (89). Even at week 6 post-implantation,
0GC and 0.1GC samples showed the presence of intact hydrogel, even though the hydrogel showed
some signs of disintegration at that time. At week 6 post implantation, the 0.2GC hydrogel showed
significant decrease in size, showing the degradability of the hydrogel in vivo. Compared to the
0.2GC hydrogel, the 0.3GC and 0.5 GC hydrogels showed significantly higher degradation. Even
at week 2, only very small amounts of hydrogel residues were present. By week 4, complete
degradation of the hydrogels was observed at the implantation site. The data show significant
increase in degradation of the hydrogels with increase in degree of acetylation of HPP-GC. This
is supported by the extremely fast degradation of the 1GC hydrogel. Only very small residue of
the 1GC hydrogel was observed at week 1 post-implantation and by week 2, no hydrogel residue
was observed, demonstrating the complete degradation of the hydrogel. The study demonstrated
the excellent in vivo degradation of acetylated HPP-GC hydrogels and the effect of degree of
acetylation on the rate of degradation of the hydrogels.
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Figure 3.3a: In vivo degradation studies by subcutaneous implantation – representative gross
morphology of explanted hydrogels by SEM (25x, inset 100x).’*’ sign indicates the GC
hydrogel, ‘ ’ sign indicates the fibrous layer surrounding the hydrogel
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Week 1

Week 2

Figure 3.3b: In vivo degradation studies by subcutaneous implantation – representative gross
morphology of explanted hydrogels by SEM (25x, inset 100x).’*’ sign indicates the GC
hydrogel, ‘ ’ sign indicates the fibrous layer surrounding the hydrogel
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Figure 3.4a: In vivo degradation studies by subcutaneous implantation – representative image of
H&E sections of explanted hydrogels at different time points (10x)
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Figure 3.4b: In vivo degradation studies by subcutaneous implantation – representative image of
H&E sections of explanted hydrogels at different time points (10x)
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The results were further corroborated by the histological evaluation of the explanted
samples as a function of time. Figures 3.4a and b show H&E staining, showing in vivo degradation
of the acetylated HPP-GC hydrogels at different time points upon subcutaneous implantation.
Sham group at week 1 showed significant cellular infiltration, presumably due to the acute
inflammatory phase following the surgical incision. However, at week 2, the inflammatory cell
infiltrate disappeared and normal skin tissue morphology was observed. At weeks 4 and 6, the
sham sample showed a response similar to that at week 2, demonstrating that the acute
inflammatory phase had subsided by week 1 and healing was complete by week 2. In the case of
the 0GC hydrogel, week 1 showed the presence of intact hydrogel under the skin with minimal
cell infiltrate. The hydrogel was surrounded by a thin fibrous capsule, which showed the presence
of some inflammatory cells. At weeks 2 and 4, the response was found to be similar to that at week
1, with more or less intact hydrogel present under the skin with minimal cell infiltration along with
the presence of a fibrous sheath that showed inflammatory cell activity. Even at week 6, the
histological image showed the presence of an intact hydrogel with minimal cell infiltration, along
with the presence of a thin fibrous layer and no degradation. In the case of 0.1GC, the image at
week 1 showed an intact hydrogel with a thin fibrous layer and minimal cell infiltration. At week
2, the hydrogel was intact with a fibrous layer. The presence of inflammatory cells was found to
be more profound compared to 0GC. At week 4, the gel was still intact with minimal cell
infiltration. However, at week 6, the gel showed some disintegration compared to 0GC gel at that
time point. The image at week 1 for 0.2GC on the other hand showed a fibrous layer and significant
inflammatory cell infiltration along with hydrogel degradation. A previous report has shown that
non-degraded chitosan gets stained with eosin, imparting a reddish pink color to the hydrogel. In
contrast, degraded chitosan gets stained with hematoxylin (a basophilic stain), which is indicated
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by blue color. This can be explained as follows. When chitosan is present in physiological
condition, it has a positive charge and gets stained with eosin, which is a negatively charged stain.
However, when chitosan degrades, a shift in charge occurs and it becomes negatively charged,
causing a change in the staining mechanism (117). Images at weeks 2 and 4 showed profound
degradation of the 0.2GC hydrogel as indicated by the degraded gel (blue color) along with
inflammatory cell infiltration. At week 6, it showed maximum degradation with very few residual
gel fragments and minimal inflammatory cell presence. The 0.3GC and 0.5GC hydrogels showed
significant cell infiltration along with hydrogel degradation at weeks 1 and 2. At week 4, complete
degradation of the hydrogel occurred and the gel was completely cleared from the implant site.
Significant infiltration of inflammatory cells at earlier time point can significantly facilitate
hydrogel degradation. Degradation of the hydrogels in the study happened due to the secretion of
lysozyme by inflammatory cells such as neutrophils and macrophages that infiltrate the gels (118).
Oxidants are reported to be essential to mediate lysozyme activity and neutrophils are shown to
release oxidants at the implantation sites. The degraded hydrogels are then ingested by the
macrophages, which helps in eliminating them from the implantation site. Among all the gels
tested, the 1GC hydrogel showed maximum degradation at week 1. Inflammatory cell infiltration
had also subsided by week 1. By week 2 complete clearance of the fibrous layer and gel from the
implant site was observed. These observations indicate that acetylation of HPP-GC hydrogels can
result in a family of polymers that can show a range of degradation and thereby allow the
development of tailored hydrogels for a variety of regenerative applications.
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3.4. Conclusion
This chapter focused on demonstrating the in vivo biodegradability of acetylated HPP-GC
hydrogels. The hydrogels were subcutaneously implanted on the dorsal surface of BALB/c mice.
H&E staining and SEM imaging showed the presence of a fibrous layer surrounding the hydrogel.
Results indicate that 0GC was the slowest-degrading hydrogel and remained intact till week 6. The
fastest-degrading hydrogel was 1GC, which degraded within 1 week. The results of this study
demonstrate the feasibility of designing and preparing enzymatically crosslinked acetylated HPPGC hydrogels with a wide range of degradation properties for different regenerative applications.
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CHAPTER 4: EVALUATION OF CELLULAR VIABILITY AND
SPREADING IN HPP-GC/TYR-GELATIN COMPOSITE HYDROGELS

4.1. Introduction
4.1.1. Glycol chitosan-gelatin composite
As shown in Chapters 1 and 2 and in the work of Gohil et al (89), GC showed cellular
viability but did not display cell spreading. In order to improve the biological properties of GC,
mixing with other polymers that have cell adhesion properties can increase adhesion and spreading
of cells encapsulated in HPP-GC hydrogels. Gelatin is basically derived from collagen by partial
denaturation. Its structure is NH2COOH–CH–R (R stands for glycin, proline or hydroxyproline).
Collagen is known to have antigenicity because it is obtained from animal tissues, whereas gelatin
has less antigenicity and contains the signaling molecules that are present in collagen. Gelatin
contains sequences similar to Arg–Gly–Asp (RGD), which can promote cell adhesion,
differentiation, proliferation and migration (121). Besides, gelatin is also reported to have
biocompatibility, biodegradability, plasticity and cell-adhesive nature (122). Several groups have
studied the potential of incorporating gelatin in chitosan-based materials for different applications
such as cardiac (123), cartilage (124), bone (121, 125), hepatic (126) and skin (127) regeneration.
Chitosan-gelatin composite can be prepared by a simple mixing of the two solutions or by using
different crosslinkers such as glutaraldehyde (128), genipin (129) or by using various enzymes
(130).

4.1.2. Literature review
Arakawa et al prepared an in situ-photocrosslinkable hydrogel using methacrylated GC
(MeGC) and semi-interpenetrating collagen (Col) for application in bone regenerative engineering.
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Photocrosslinking was performed in the presence of a riboflavin photinitiator using light of
wavelength 400-500 nm. Collagen was incorporated to improve the mechanical strength and celladhesive nature of the MeGC hydrogel. The study showed that the MeGC-Col composite showed
better attachment, spreading and proliferation of bone marrow stromal cells in comparison to
MeGC alone (76). Pok et al prepared multilayered three dimensional scaffolds for cardiac tissue
engineering using polycaprolactone (PCL) as the core containing chitosan-gelatin hydrogel in it.
The PCL core provided tensile strength and surgical handling. The porous chitosan-gelatin
hydrogel was included for providing cellular attachment and mechanical support, which is very
essential for cardiomyocyte functioning and migration. Electron microscopy revealed that the pore
size of the hydrogel was ~80 µm and also showed the viability and migration of neonatal rat
ventricular myocytes. The scaffold presented a biomimetic environment and could be used as a
cardiac patch for repairing congenital cardiac defects (123). Kathurai et al prepared a hybrid
cryogel made of chitosan and gelatin for cartilage tissue engineering application. In vitro study
showed that the cryogels showed better cellular proliferation of cos-7 cell line (122). Cheng et al
used a thermosensitive hydrogel made of chitosan-gelatin-β-GP salt for intervertebral disc nucleus
pulposus (NP) regeneration. Addition of gelatin to the hydrogel significantly improved gel
strength, gelation time and gene expression. The hydrogel also showed cell viability and
proliferation of NP cells (131). Nagahama et al used chitosan hydrogel to prepare chitosan/gelatin
membrane for biomedical application. They carried out a cell adhesion study using MG-63
osteoblast-like cells on the membranes. The study revealed that the membranes were able to attach
cells within 1 day (132). Han et al designed chitosan-gelatin sponge for skin regenerative
application. In vitro study with the sponge showed cell attachment and proliferation for up to 21
days. In vivo study also indicated the ability of the sponge to enhance cell attachment for wound
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healing (127). Miranda et al used a porous chitosan-gelatin scaffold for bone regenerative
engineering. Rat bone marrow mesenchymal stem cells cultured in the three dimensional scaffold
showed cell viability, adhesion and spreading. In vivo study also showed cell adhesion and
differentiation of the stem cells in the direction of osteogenic lineage (125). Amini et al
demonstrated the feasibility of developing an injectable hydrogel system using gelatin modified
with tyramine in the presence of HRP and H2O2 as a delivery vehicle for osteoblast cells. The
gelatin hydrogels showed MCT3T3-E1 osteoblast cell adhesion and spreading in the three
dimensional environment (133). In the present chapter, the feasibility of developing a composite
injectable hydrogel by crosslinking HPP-GC and tyramine gelatin (Tyr-Gelatin) in the presence of
HRP and H2O2 will be discussed. The swelling properties of the composite hydrogel as well as cell
adhesion and spreading in the composite hydrogels will also be presented.

4.2. Materials and methods
4.2.1. Materials
The following items and chemicals were used for carrying out the experiments: GC (Sigma
Aldrich), MES powder (Fisher), EDC (Sigma Aldrich), NHS (98%) (Sigma Aldrich), HPP (98%)
(Sigma Aldrich), HRP (Sigma Aldrich), hydrogen peroxide (Sigma Aldrich), gelatin (Type A)
(MP), tyramine-HCl

(Sigma Aldrich),

LIVE/DEAD® viability/cytotoxicity kit

(Life

Technologies), and 7F2 cells (ATCC® CRL-12557TM).

4.2.2. Preparation of HPP-modified glycol chitosan
HPP modification was done on GC using carbodiimide-based coupling reaction. For
preparing a batch of HPP-GC, 500 mg of GC was dissolved in 350 mL of 1 M MES solution (pH
5.5). The solution containing GC was dissolved by stirring at room temperature (RT) for 3 h. For
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HPP-coupling, EDC (2.608 mmol) and NHS (2.172 mmol) were dissolved in 50 mL of 1 M MES
solution for 5 min, followed by the addition of HPP (3.009 mmol) and reaction for 1 h at RT. This
solution was then added to the solution containing GC and kept for 24 h at RT. The solution
mixture was then dialyzed against water using dialysis tubings with cut-off size of 10,000 Da.
Dialysis was carried out for 3 days during which the water was changed 6 times. After dialysis,
the solution was frozen at -20oC. The frozen solution was then lyophilized for 3 days and stored at
-20oC.

4.2.3. Preparation of tyramine-modified gelatin
Tyramine modification was performed on gelatin using carbodiimide-based coupling
reaction. For preparing a batch of Tyr-Gelatin, 875 mg of gelatin (Type A) was dissolved in 20
mL of water under stirring at 37 oC for 2 h. After dissolving the gelatin, 55 mL of MES buffer was
added to the solution. Tyramine-HCl (2.937 mmol) was added to the solution followed by EDC
(2.660 mmol) and NHS (1.303 mmol). The solution was allowed to react at RT for 24 h. The
solution was then dialyzed against water using dialysis tubings with cut-off size of 10,000 Da.
Dialysis was carried out for 3 days during which the water was changed 6 times. After dialysis,
the solution was frozen at -20oC. The frozen solution was then lyophilized for 3 days and stored at
-20oC.

4.2.4. Characterization of HPP-modified glycol chitosan and tyramine-modified gelatin
The extent of phenolic group substitution in GC and gelatin was characterized using a UV
spectrophotometer (Evolution 60, Thermoscientifc). For determining the extent of HPP
modification in GC, unmodified and HPP-modified GC were dissolved in ultra-pure water at a
concentration of 1 mg/mL and the absorbance was measured at 275 nm. Phenolic group
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substitution was calculated by plotting a calibration curve obtained using known concentrations of
HPP dissolved in ultra-pure water. Similarly, for determining the extent of tyramine modification
in gelatin, unmodified and tyramine-modified gelatin were dissolved in ultra-pure water at a
concentration of 1 mg/mL and the absorbance was measured at 275 nm. Phenolic group
substitution was calculated by plotting a standard calibration curve obtained using known
concentrations of tryamine-HCl dissolved in ultra-pure water.

4.2.5. Preparation of composite hydrogels using HPP-modified glycol chitosan and tyraminemodified gelatin
HPP-GC solution was prepared in α-MEM at a concentration of 20 mg/mL. Tyr-Gelatin
solution was also prepared in α-MEM at a concentration of 20 mg/mL. (Note: α-MEM was always
thawed at 37 oC prior to dissolving gelatin because gelatin is less soluble at lower temperatures).
The two solutions were mixed in the following different ratios (v/v) – GC:Gelatin (10:90),
GC:Gelatin (30:70), GCGelatin (50:50), GC:Gelatin (70:30) and GC:Gelatin (90:10) – and kept
for vortexing at 1500 rpm for 24 h at RT to ensure uniform mixing. HPP-GC alone and Tyr-Gelatin
alone were used as controls. Either 20 units or 5 units of HRP was added to the solution and mixed
uniformly. Enzymatic crosslinking was done by adding H2O2. The H2O2 concentration in the final
solution was 7.34 mM.

4.2.6. Swelling behavior of HPP-modified glycol chitosan/tyramine-modified gelatin composite
hydrogels
Hydrogels of HPP-GC alone, gelatin alone, GC:Gelatin (10:90), GC:Gelatin (30:70), GC:
Gelatin (50:50), GC:Gelatin (70:30) and GC:Gelatin (90:10) were prepared in syringe molds as
described in section 4.2.5. Four hydrogel samples were tested for each polymer (n=4). Hydrogels
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prepared from 150 µL of the respective polymer solutions were placed in glass vials and the initial
weights were determined (Wsi). To each of the vials, 1mL PBS was added and incubated in a
shaker at 37 oC. Weights of the hydrogels with the vials were determined after removing excess
PBS (Wsf) at day 1, day 3, day 5, day 7 and day 14. The PBS removed was replaced with fresh PBS
after the measurement at each time point. The swelling ratio was determined using the following
equation [5].

%Swelling 

Wsf  Wsi
Wsi

 100      [5]

4.2.7. Viability and morphological study of HPP-modified glycol chitosan and semiinterpenetrating gelatin hydrogels with encapsulated osteoblast cells
Osteoblastic cell line 7F2 (derived from mouse bone marrow) was used for the study. Cells
were grown and maintained in α-MEM (2 mM L-glutamine, 1 mM sodium pyruvate, with no
ribonucleosides and deoxyribonucleosides) with 10% FBS and 1% pen-strep. HPP-GC solution
was prepared in α-MEM at a concentration of 20 mg/mL. Gelatin A solution was prepared in αMEM at a concentration of 20 mg/mL by vortexing at 37 oC. Both solutions were sterilized under
UV light for 30 min prior to the cell encapsulation step. HRP was added to these solutions at a
concentration of 20 units/mL. Cells were trypsinized and suspended in GC:Gelatin (70:30),
GC:Gelatin (90:10) and HPP-GC alone at a cell density of 0.8 million per mL. To prepare the
hydrogel, 10 µL of the polymer solution with cells and HRP was mixed with H2O2 in a syringe
mold. H2O2 concentration in the final solution was 7.34 mM. The hydrogel with the encapsulated
cells was incubated in Costar® ultra-low attachment plate with media at 37 oC and 5% CO2. Media
was changed every 3 days to keep the cells healthy. At specific time points, the hydrogel with the
encapsulated cells was transferred to MatTek glass bottom 35 mm dish and stained using
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LIVE/DEAD® viability/cytotoxicity kit for mammalian cells. Confocal microscopy imaging was
done using a Zeiss LSM 510 Meta microscope.

4.2.8. Viability and spreading of osteoblast cells encapsulated in HPP-modified glycol
chitosan/tyramine-modified gelatin composite hydrogels
Osteoblastic cell line 7F2 (derived from mouse bone marrow) was used for the study. Cells
were grown and maintained in α-MEM (2 mM L-glutamine, 1 mM sodium pyruvate, with no
ribonucleosides and deoxyribonucleosides) with 10% FBS and 1% pen-strep. Separate solutions
of HPP-GC and Tyr-Gelatin dissolved in α-MEM at concentrations of 20 mg/mL were mixed at
different ratios (v/v) – GC:Gelatin (10:90), GC:Gelatin (30:70), GC:Gelatin (50:50), GC:Gelatin
(70:30) and GC:Gelatin (90:10) – and kept for vortexing at 1500 rpm for 24 h to ensure uniform
mixing of the polymer solutions. Solutions of HPP-GC alone and gelatin alone were used as
controls. The polymer solutions were sterilized under UV light for 30 min prior to the cell
encapsulation step. HRP was added to these solutions at a final concentration of 20 units/mL. Cells
were trypsinized and suspended in HPP-GC/Tyr-Gelatin composite solutions at a cell density of
0.8 million per mL. To prepare the hydrogel, 10 µL of the polymer solution with cells and HRP
was mixed with H2O2 in a syringe mold. H2O2 concentration in the final solution was 7.34 mM.
The hydrogel with the encapsulated cells was incubated in Costar® ultra-low attachment plate
with media at 37 oC and 5% CO2. Media was changed every 3 days to keep the cells healthy. At
specific time points, the hydrogel with encapsulated cells was transferred to MatTek glass bottom
35 mm dish and stained using LIVE/DEAD® viability/cytotoxicity kit for mammalian cells.
Confocal microscopy imaging was done using a Zeiss LSM 510 Meta microscope.
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4.2.9. Statistical analysis
All results presented in the chapter are expressed as mean ± standard deviation. Statistical
analysis was done using One-way ANOVA followed by SNK test in SigmaStat (ver 2.3).
Statistical significance was set at p < 0.05.

4.3. Results and discussion
4.3.1. Synthesis of HPP-modified glycol chitosan and tyramine-modified gelatin
HPP-GC polymer was prepared as mentioned in section 2.2.2. Tyramine is also a phenolcontaining molecule similar to HPP. Therefore, Tyr-Gelatin was prepared using carbodiimide
chemistry using EDC and NHS by a method similar to that described in section 2.3.1. Conjugation
occurs through the formation of an amide bond between the amine group of tyramine and
carboxylic group of gelatin after it has been activated by EDC and NHS (133, 134).

EDC, NHS

+
Gelatin

Tyramine

Tyr-Gelatin

Figure 4.1: Schematic showing Tyr-Gelatin synthesis (133)

4.3.2. Characterization of HPP-modified glycol chitosan and tyramine-modified gelatin
Phenol content in HPP-GC and Try-Gelatin was quantified using UV spectroscopy. Figure
4.2 shows the standard curves obtained using different concentrations of HPP and tyramine-HCl
separately, indicating linearity in the concentration range tested. Absorbance values for HPP-GC
and Tyr-Gelatin were also recorded at 275 nm followed by the subtraction of background
absorbance values corresponding to GC and gelatin alone, respectively. Concentration of phenol
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group per mg of HPP-GC polymer and Tyr-Gelatin was obtained as 0.377 ± 0.061 µmol and 0.228
± 0.001 µmol, respectively. Results suggest the successful incorporation of phenolic groups in GC
and gelatin.

Figure 4.2: (A) Standard curve used to determine HPP concentration in GC (B) Standard curve
used to determine Tyr concentration in gelatin
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4.3.3. Gelation time of HPP-modified glycol chitosan/tyramine-modified gelatin composite
hydrogels
HPP-GC and Tyr-Gelatin solutions in α-MEM were mixed in different ratios and
enzymatically crosslinked using 20 units of HRP/mL. H2O2 was added at a concentration of 7.34
mM. The mechanism of gelation is the same as described in section 2.3.1. The ratios used for the
studies were GC: Gelatin (10:90), GC: Gelatin (30:70), GC: Gelatin (50:50), GC: Gelatin (70:30)
and GC: Gelatin (90:10). HPP-GC alone and Tyr-gelatin alone were used as controls. Gelation
times recorded using vial inversion test are shown in Figure 4.3. Results indicate a significant
difference between the gelation times of HPP-GC alone compared to the other groups tested.
Gelation time for HPP-GC alone (4s) was the lowest and that for gelatin alone (16 s) was the
highest. Gelation times for HPP-GC/Tyr-Gelatin composites were in between gelation times for
HPP-GC and Tyr-Gelatin. As can be seen, increasing GC concentration led to a decrease in the
gelation time. No significant differences in gelation times were observed between the HPP-GC
alone hydrogel and GC-gelatin (90:10) hydrogel.
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Figure 4.3: Gelation times of HPP-GC/Tyr-Gelatin composites. Data are expressed as mean ±
standard deviation with n = 3. One way Anova followed by SNK comparing different groups
against HPP-GC alone. p*** < 0.001 vs. Gelatin alone, GC:Gelatin (10:90), GC:Gelatin (30:70),
GC:Gelatin (50:50), GC:Gelatin (70:30)

Figure 4.4: (A) Shows free-flowing polymer solution (B) Shows hydrogel formation in all ratios
of HPP-GC/Tyr-Gelatin
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Figure 4.4 shows the ability of the composites to form robust hydrogels at all the
concentrations studied. As can be seen, HPP-GC alone results in a transparent gel whereas gelatin
alone results in a translucent gel. The composite gels showed higher transparency with an increase
in GC content.

4.3.4. Swelling behavior of HPP-modified glycol chitosan/tyramine-modified gelatin composite
hydrogels
Swelling behavior of different enzymatically crosslinked HPP-GC/Tyr-Gelatin composite
hydrogels was studied by incubating them in PBS at 37 oC. At predetermined time points, PBS
was removed and wet weight was measured to obtain percentage swelling as a function of time.
Figure 4.5 depicts the swelling percentage on different days – day 1, day 3, day 5, day 7 and day
14 – for all the hydrogels. Swelling percentage was found to decrease over time for all HPPGC/Tyr-Gelatin composites as well as for the Tyr-Gelatin alone and HPP-GC alone hydrogels.
Figure 4.6 shows the statistical comparison with respect to time within the same hydrogel. Table
4.1 and Figure 4.7 show the statistical comparison of the behavior of HPP-GC alone against the
other hydrogels.
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Figure 4.5: Swelling behavior of HPP-GC/Tyr-Gelatin composites

Table 4.1: Statistical analysis corresponding to Figure 4.6 below, comparing different time
points within the same group. Data are expressed as mean ± standard deviation (n=4)
A

HPP-GC

P*** < 0.001 vs. days 1, 3, 5, 7, 14), p### < 0.001 vs. days 5, 7, 14,

alone

p## < 0.01 vs.day 3

B

Gelatin alone

p*** < 0.001 vs. days 1, 3, 5, 7, 14

C

10:90

P*** < 0.001 vs. days 7, 14

D

30:70

p** < 0.01 vs. day 14, p* < 0.05 vs. days 5, 7

E

50:50

p*** < 0.001 vs. days 1, 3, 5, 7, 14

G

90:10

p*** < 0.001 vs. days 7,14, p** < 0.01 vs. day 5, p* < 0.05 vs. day 3,
p### < 0.001 vs. days 7, 14, p# < 0.05 vs. day 5, p^^ < 0.01 vs. days 7, 14
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Figure 4.6: Swelling behavior of HPP-GC/Tyr-Gelatin composite hydrogels. Statistics
comparing different time points within the same group are shown in Table 4.1 above
83

Figure 4.7: Swelling behavior of HPP-GC/Tyr-Gelatin composite hydrogels. Data are expressed
as mean ± standard deviation with n = 4. One way Anova followed by SNK test, comparing the
behavior of HPP-GC alone against that of all other hydrogels with respect to different time
points. (A) Day 1 HPP-GC alone: p** < 0.10 vs gelatin alone, (B) Day 3 HPP-GC alone: p** <
0.10 vs GC:Gelatin (90:10), p* < 0.05 vs GC:Gelatin (10:90), GC: Gelatin (30:70), GC:Gelatin
(50:50), GC:Gelatin (70:30), (C) Day 5 HPP-GC alone: p* < 0.10 vs GC:Gelatin (90:10)
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Shrinkage of the hydrogel was much greater for HPP-GC alone and gelatin alone as
compared to all the different composite hydrogels studied. As seen in Figure 4.7, decrease in
swelling for HPP-GC alone at day 3 was statistically significant compared to all other hydrogels
except gelatin alone. However, at day 5, decrease in swelling for HPP-GC alone was different only
to GC:Gelatin (90:10). At days 7 and 14, no statistically significant difference in swelling was
observed between the HPP-GC alone hydrogel and gelatin alone hydrogel as well as between the
different composite hydrogels tested. Similar to the observations detailed in section 2.3.4, the HPPGC alone hydrogel showed a continuous decrease in weight upon incubation in PBS till 3 days
and after that no further decrease was observed. The Tyr-Gelatin hydrogel on the other hand
showed a faster decrease in weight at day 1 itself and no further weight decrease was observed
after that. The composite hydrogels [GC-gelatin (10:90); GC-gelatin (30:70); GC-gelatin (50:50);
GC-gelatin (70:30)] show behavior similar to Tyr-Gelatin hydrogel, with a faster decrease in
weight at day 1 and no further weight decrease after that. However, the extent of weight decrease
in these composite hydrogels was significantly lower than that of Tyr-gelatin gel. The composite
hydrogel GC-gelatin (90:10) on the other hand showed behavior similar to that of HPP-GC
hydrogel with a continuous decrease in weight till day 7. The data demonstrate the feasibility of
modulating the swelling behavior of HPP-GC and Tyr-gelatin hydrogels by developing composite
hydrogels. The decrease in swelling with respect to time may be attributed to the increase in
crosslinking density of these hydrogels over time. Similar behavior was observed in the case of
acetylated HPP-GC hydrogels as discussed in section 2.3.4. Further studies are required to clearly
understand the factors contributing to the significant decrease in weight for these hydrogels upon
incubation in PBS.
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Figure 4.8: Swelling behavior of hydrogels prepared using 5 units of HRP/mL. Data are
expressed as mean ± standard deviation with n = 4.One way Anova followed by SNK test. HPPGC alone: p*** < 0.001 vs. days 1, 3, 7, GC: Gelatin (50:50): p### < 0.001 vs. day 7, p## < 0.01
vs. day 3, p# < 0.05 vs. day 1

A preliminary study was conducted by varying the concentration of HRP to understand the
effect of reagent concentrations on the swelling behavior of HPP-GC and composite hydrogels.
The study tested the HPP-GC hydrogel and GC:Gelatin (50:50) composite hydrogel prepared using
5 units of HRP instead of 20 units used in the previous study (Figures 4.5 to 4.7). Figure 4.8 shows
the results of the swelling study. As in the case of 20 units of HRP, the hydrogels showed a decrease
in weight upon incubation in PBS. No difference in swelling behavior was observed and the trends
in Figure 4.8 were similar to those observed with hydrogels prepared using 20 units of HRP
(Figures 4.5 to 4.7). It has been reported that by changing the HRP and H2O2 concentrations, the
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crosslinking density can be varied (108). Further studies are required using a wide range of HRP,
H2O2 and HPP concentrations to understand their effect on the gelation and swelling properties of
the enzymatically crosslinked hydrogels.

4.3.5. Viability and morphological study of HPP-modified glycol chitosan and semiinterpenetrating gelatin hydrogel with encapsulated osteoblast cells

Figure 4.9: Confocal image showing viability and morphology of 7F2 osteoblast encapsulated in
HPP-GC/semi-interpenetrating gelatin hydrogel (20x)

A previous study has shown that addition of collagen to photocrosslinked GC hydrogels
can increase cell adhesion and spreading (76). So, a study was performed to develop a semiinterpenetrating network by mixing HPP-GC and unmodified gelatin followed by crosslinking in
the presence of HRP and H2O2. Cell suspension was added to the polymer solution before gelling
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as explained in section 4.2.7. LIVE/DEAD® staining was performed at days 7 and 14 to evaluate
the viability and spreading of the encapsulated cells in the hydrogel (Figure 4.9). As shown in the
figure, the encapsulated cells showed 100% viability at days 7 and 14 in culture irrespective of
HPP-GC concentration. As reported before (section 2.3.6), the cells encapsulated in HPP-GC alone
hydrogel did not show any cell spreading at both the time points. The addition of gelatin to the
hydrogel slightly improved cell spreading in the hydrogel. The GC:Gelatin (90:10) group showed
cell behavior similar to that of the HPP-GC alone hydrogel, with most of the encapsulated cells
showing a round morphology at day 7. At day 14, a few spread cells were observed along with
predominantly round cell morphology and, more importantly, the spread cells were localized at
certain areas presumably rich in gelatin. The GC:Gelatin (70:30) group on the other hand showed
improved cell spreading at both days 7 and 14. However, even at this gelatin concentration, the
spread cells were found in localized areas along with cells having round morphology. The results
are in contrast with the data reported elsewhere using collagen-MeGC hydrogels, where a small
concentration of collagen was able to impart significant cell spreading (76). The presence of
localized cell spreading in the present study implies the potential separation of HPP-GC and gelatin
phases in the hydrogel and the process not leading to a homogeneous hydrogel formation.

4.3.6. Viability and cell spreading study of HPP-modified glycol chitosan/tyramine-modified
gelatin composite hydrogels with encapsulated 7F2 osteoblast cells
The study was carried out to investigate the uniformity of cell spreading in the composite
hydrogels by using Tyr-Gelatin to form interpenetrating polymer networks. HPP-GC and TyrGelatin composites were prepared and 7F2 cells were encapsulated to obtain three dimensional
hydrogels (section 4.2.8). Huang et al reported that when chitosan and gelatin solutions were kept
at room temperature for longer times, they showed phase separation with gelatin at the bottom and
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chitosan on top. (135). Hence, the hydrogel was prepared after incubating the composite solution
in a shaker for 24 h followed by vortexing before cell encapsulation in order to avoid the reported
phase separation between the different solutions. To prevent cell adhesion on the culture plate, the
hydrogel with encapsulated cells was cultured on low attachment dish and transferred to glass
bottom dish prior to confocal imaging. Viability test was performed at days 7 and 14.
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Figure 4.10: Confocal image showing viability and morphology of 7F2 osteoblast cells
encapsulated in HPP-GC/Tyr-Gelatin composite hydrogel (20x)
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LIVE/DEAD® staining was performed at days 7 and 14 to evaluate the viability and
spreading of the encapsulated cells in the hydrogel (Figure 4.10). As indicated by the green
fluorescence in Figure 4.10, majority of the cells showed viability in HPP-GC alone (control), TyrGelatin alone (control) and all composite hydrogels irrespective of the HPP-GC concentration.
However, HPP-GC alone showed no cell spreading at days 7 and 14. Tyr-Gelatin, known for its
cell adhesion and spreading property (133), showed uniform cell spreading at day 7, which
increased significantly at day 14. Addition of Tyr-Gelatin improved spreading in the composites.
GC:Gelatin (10:90) hydrogel showed cell spreading at day 7 along with few cells with round
morphology. Cell spreading increased significantly at day 14 and was uniform throughout the gel.
GC: Gelatin (30:70) showed little cell spreading along with cells with round morphology at day 7.
However, at day 14, the cells showed uniform spreading in majority of the areas. However, few
areas can be observed with very few cells, showing both round cell and spread cell morphology as
indicated in the image (in the 3rd column). The GC: Gelatin (50:50) hydrogel showed behavior
similar to that of GC: Gelatin (30:70) with some cell spreading at day 7 followed by uniform cell
spreading except in certain areas by day 14 (image in the 2nd column). Unlike these groups, GC:
Gelatin (70:30) and GC: Gelatin (90:10) showed minimal cell spreading at day 7. However, by
day 14, significant increase in cell spreading was observed in certain areas of the gel (2nd column).
At the same time, many areas in the gels showed cells with round morphology in both these gels
(3rd column). The reason for localized cell spreading can be due to non-uniform gelation of gelatin
in the composite, causing cells to spread in the areas rich in gelatin. The study showed that in order
to achieve uniform cell spreading within the hydrogel, high concentrations of gelatin are required,
presumably due to the non-uniform distribution of gelatin within the gel.
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4.4. Conclusion
The study showed the development of composite injectable hydrogels based on HPP-GC
and gelatin, and investigated the maintenance of cell viability and cell spreading in the hydrogels.
HPP-GC and Tyr-Gelatin polymers were synthesized and then characterized using UV
spectroscopy. HPP-GC/Tyr-Gelatin composite hydrogels were prepared using enzymatic
crosslinking. Swelling behavior of the composite hydrogels in PBS showed a decrease in
percentage swelling, thereby implying an increase in crosslinking density over time. Cell viability
was observed in the controls and all the composite hydrogels irrespective of the composition.
Uniform cell spreading was observed in the GC: Gelatin (10:90) hydrogel at days 7 and 14. As the
gelatin concentration decreased, areas with cells showing round morphology increased, indicating
the non-uniform distribution of gelatin within the crosslinked hydrogel matrix. This implies the
need to develop a more robust method such as the conjugation of cell-adhesive peptide directly on
HPP-GC to support uniform cell spreading.
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FUTURE DIRECTIONS
The goal of the study discussed in Chapters 2-4 was to address the two limitations of
enzymatically crosslinked HPP-GC hydrogels, namely the lack of hydrogel degradation and lack
of cell spreading in the hydrogels. Chapter 2 demonstrated the feasibility of making injectable,
degradable acetylated HPP-GC hydrogels and their potential for developing systems for controlled
protein delivery. Results from an in vitro study showed that the release of encapsulated FITCalbumin was dependent on the degradation of the hydrogels. Increasing the degree of acetylation
of the hydrogels resulted in faster degradation, leading to an increase in protein release. As the
next step, these results need to be corroborated by in vivo studies to develop translational
technologies. Subcutaneous implantation of the acetylated HPP-GC hydrogels containing protein
tagged with a fluorescent dye can be used in conjunction with an in vivo imaging system to noninvasively monitor the protein release.
Chapter 3 demonstrated the in vivo biodegradability of injectable acetylated HPP-GC
hydrogels. Results confirmed that the degree of acetylation could be used to tailor the in vivo
degradation of the hydrogels. In addition to biodegradation, biocompatibility of the hydrogels is a
very important property required for biomedical applications. Histomorphometric analysis needs
to be performed to assess cellular response to the hydrogels. Cell response can be determined by
quantifying the presence of inflammatory cells such as lymphocytes, macrophages, foreign body
giant cells and polymorphonuclears using H&E stained images. Quantification of inflammatory
marker cells need to be scored from absence (-) to significant presence (+++) to assess the severity
of the cell response to the hydrogels.
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Chapter 4 investigated composite injectable hydrogels prepared by combining HPP-GC
and Tyr-gelatin, and assessed the cell spreading properties of these hydrogels. Uniform cell
spreading was observed only in the composite with the highest concentration of gelatin; cell
spreading property decreased with a decrease in the gelatin content in the hydrogel. As the next
step, a more robust system is required to obtain uniform cell spreading in HPP-GC hydrogels. One
direction that can be pursued is to use RGD (Arginine-Glycine-Aspartic acid), which is a tripeptide
sequence that is ubiquitous in different extracellular matrix proteins such as fibronectin, laminin
and collagen and that has been reported to promote cellular adhesion and spreading. Chemically
conjugating RGD to HPP-GC polymer using standard carbodiimide chemistry could lead to
uniform cell spreading in the system.
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APPENDIX

A1. Sample calculation for labeling acetylated glycol chitosan with 0.1GC as the example
Acetic Anhydride (AA)
Density = 1.08 g/mL
Molecular weight = 102.09 g/mol
Volume of AA taken = 4.6 µL
Moles of AA = (4.6 x 10-3 x 1.08)/102.09 = 4.866 x 10-5 mol
Glycol chitosan [Completely deacetylated polymer with degree of polymerization equal to 400]
Molecular weight = 205 x 400 = 82000 g/mol
Weight of GC taken = 0.1 g
Moles of GC = 0.1/82000 = 1.219 x 10-6 mol
1 mol of GC polymer contains 400 mols of NH2. Therefore,
Moles of NH2 = 1.219 x 10-6 x 400 = 4.878 x 10-4 mol
Molar ratio of AA to NH2 = (4.866 x 10-5)/(4.878 x 10-4) = 0.0997 (Rounded off to 0.1)
Hence, the polymer was labeled 0.1GC
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